# Appendix — Bluestein v. Skinner

> Briefs, arguments, decisions, and more.

URL: https://www.frixlaw.com/law-library/documents/brief%3Amicro_IA40385020_3070%3A2

## Record

- **Collection:** Supreme Court brief
- **Document type:** Appendix
- **Published:** January 1, 1991
- **Citation:** 498 U.S. 1083

## Text

IN THE

Supreme Court of the Buited States

OCTOBER TERM, 1990

MICHAEL §. BLUESTEIN, et al.,
Petitioners,
Vv.

SAMUEL K. SKINNER,
Secretary of Transportation, et al.,
Respondents.

Petition for a Writ of Certiorari to the
United States Court of Appeals
for the Ninth Circuit

APPENDIX TO
PETITION FOR. A WRIT OF CERTIORARI

WALTER KAMIAT
LAURENCE GOLD

(Counsel of Record)
815 16th Street, N.W.
Washington, D.C. 20006
(202) 637-5390

[Attorneys for Individual Petitioners Listed on Inside Cover]

WILSON - EPES PRINTING Co., INC. - 789-0096 - WASHINGTON, D.C. 20001

@ ES» co

1 tite

GARY GREEN
JERRY ANKER

1625 Massachusetts Ave., N.W.

Washington, D.C. 20036

Counsel for Air Line Pilots
Association

WILLIAM JOLLEY
204 West Linwood Boulevard
Kansas City, MO 64111

Counsel for Sheri Albert,
Charles McCune and
Independent Federation of
Flight Attendants

DEBORAH GREENFIELD
EDWARD J. GILMARTIN

1625 Massachusetts Ave., N.W.

Washington, D.C. 20036

Counsel for Association of
Flight Attendants

MICHAEL GOTTESMAN
GEORGE COHEN

Mapy GILSON

1000 Connecticut Ave., N.W.
Washington, D.C. 20036

Counsel for Association of
Professional Flight
Attendants and Independent
Union of Flight Attendants

STEPHEN P. BERZON
FRED H. ALTSHULER
MICHAEL RUBIN

177 Post Street, Suite 300
San Francisco, CA 94108

Counsel for Michael S. Bluestein

and Dean N. Chantiles

ALLISON BECK

OWEN HERRNSTADT

1300 Connecticut Ave., N.W.
Washington, D.C. 20036

Counsel for International

Association of Machinists and

Aerospace Workers

JAMES T. GRADY

GaArY S. WITLIN

25 Louisiana Avenue, N.W.

Washington, D.C. 20001

Counsel for International
Brotherhood of Teamsters,
Chauffeurs, Warehousemen
and Helpers of America

LEE SEHAM
485 Madison Avenue
New York, NY 10022

Counsel for Richard S. Linn

Scott D. RAPHAEL

1900 Avenue of the Stars

Suite 2300

Los Angeles, CA 90067

Counsel for Orange County
Airport Association

ARTHUR M. LUBY

1300 L Street, N.W.

Washington, D.C. 20001

Counsel for Transport
Workers Union of America

LARRY MANN

400 First Street, N.W.

Washington, D.C. 20001

Counsel for Transportation-

Communications International

Union

TABLE OF CONTENTS
APPENDIX A Page

Opinion of the United States Court of Appeals for
the Ninth Circuit in Michael S. Bluestein, et al. v.
Samuel K. Skinner, Secretary of Transportation,
et al., 908 F.2d 451 (July 10, 1990) 00000. la

APPENDIX B

Federal Aviation Administration, Anti-Drug Pro-
gram for Personnel Engaged in Specified Aviation
Activities; Final Rule, 58 Fed. Reg. 47024 (No-
I epee ns 16a

la
APPENDIX A

UNITED STATES COURT OF APPEALS
NINTH CIRCUIT

Nos. 88-7503, 88-7508, 89-70024,
89-70111, 89-70138 and 88-70139

MICHAEL S. BLUESTEIN; DEAN N. CHANTILES;
ORANGE COUNTY AIRPORT ASSOCIATION,

Petitioners,
v.

SAMUEL K. SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,

Respondents.

RICHARD §. LINN,

Petitioner,
v.

SAMUEL K. SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,

Respondents.

SHERI ALBERT; CHARLES MCCUNE,

Petitioners,
v.

SAMUEL K, SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,

Respondents.

2a

ASSOCIATION OF PROFESSIONAL FLIGHT ATTENDANTS,
Petitioner,
Vv.

SAMUEL K. SKINNER, Secretary of Transportation,
DEPARTMENT OF TRANSPORTATION,
FEDERAL AVIATION ADMINISTRATION,

Respondents.

INDEPENDENT UNION OF FLIGHT ATTENDANTS,
Petitioner,
V.

FEDERAL AVIATION ADMINISTRATION,
Respondent.

AIRLINE PILOTS ASSOCIATION, INTERNATIONAL,
Petitioner,
V.

FEDERAL AVIATION ADMINISTRATION,
Respondent.

Petition for Review of an Order of the
Federal Aviation Administration

Argued and Submitted Sept. 15, 1989
Decided July 10, 1990

D0 ee il aT Oe

8a

Walter Kamiat and Laurence Gold, Washington, D.C.,
for the Air Line Pilots Ass’n, Ass’n of Flight Attendants,
Intern. Ass’n of Machinists and Aerospace Workers,
Intern. Brotherhood of Teamsters, Chauffeurs, Warehouse-
men and Helpers of America, Transp.-Communications
Intern. Union.

Gary Green and Jerry Anker, Washington, D.C., for
the Air Line Pilots Ass’n.

Stephen P. Berzon, Fred H. Altshuler, and Michael
Rubin, Altshuler & Berzon, San Francisco, Cal., Seott D.
Raphael, Newport Beach, Cal., for Michael S. Bluestein,
Dean N. Chantiles, and Orange County Airport Ass’n.

Deborah Greenfield, Matthew Finucane, and Edward
Gilmartin, Washington, D.C., for the Ass’n of Flight
Attendants.

Allison Beck, Washington, D.C., for the Intern. Ass’n
of Machinists and Aerospace Workers.

James T. Grady and Wilma B. Liebman, Washington,
D.C., for the Intern. Brotherhood of Teamsters, Chauf-
feurs, Warehousemen and Helpers of America.

David Rosen and Arthur M. Luby, Washington, D.C.,
for the Transport Workers of America.

Larry Mann, Washington, D.C., for the Transp.-
Communications Intern. Union.

Lee Seham, Seham, Klein & Zelman, New York City,
Law Offices of Thornton C. Bunch, Jr., San Francisco,
Cal., for Richard S. Linn.

Stewart Weinberg, Van Bourg, Weinberg, Roger &
Rosenfeld, San Francisco, Cal., David J. Aronofsky, Arent
Fox, Kintner, Plotkin & Kahn, Washington, D.C., William
Jolley, Jolley, Walsh, Hager & Gordon, Kansas City, Mo.,
for Sheri Albert, Charles McCune, Independent Federa-
tion of Flight Attendants.

4a

Michael Gottesman, George Cohen, and Mady Gilson,
Bredhoff & Kaiser, Washington, D.C., for the Ass’n of
Professional Flight Attendants and Independent Union
of Flight Attendants.

Diane Liff, Gen. Counsel’s Office, Dept. of Transp.,
Robert V. Zener and Leonard Schaitman, Dept. of Justice,
Civ. Div., Washington, D.C., Kenneth W. Starr, Sol. Gen.,
Washington, D.C., for respondents.

Before CHAMBERS, CANBY and NORRIS, Circuit
Judges.

WILLIAM A. NORRIS, Circuit Judge:

This is a petition for review of Federal Aviation Ad-
ministration (FAA) regulations requiring random drug
testing of flight crew members, maintenance personnel,
air traffic controllers, and several other categories of
employees in the private commercial aviation industry.
Petitioners argue that the regulations violate the Fourth
Amendment and are arbitrary and capricious in violation
of §10(e) of the Administrative Procedure Act, 5 U.S.C.
§ 706(2) (A). We reject both of petitioners’ arguments
and uphold the regulations.

I. BACKGROUND
A. The Regulations

The FAA initially proposed random drug testing in an
advance notice of proposed rule making. 51 Fed.Reg.
44432 (Dec. 9, 1986). After receiving over 650 written
comments, the FAA issued a notice of proposed rule-
making. 53 Fed.Reg. 8368 -(March 14, 1988). Over 260
written comments were filed in response to this notice,
and the FAA also held a series of public hearings. The
final rule was issued on November 21, 1988. 53 Fed.Reg.
47024.

The FAA concluded that while drug use is not “wide-
spread” among commercial aviation personnel and there

++ intial

5a

is no “overwhelming” drug problem in the industry,
nevertheless the record “does show concrete evidence of
drug use in the commercial aviation sector.” 53 Fed.Reg.
47029, 47930. Accordingly, the FAA decided that “[i]n
order to ensure that aviation safety is not compromised
by a failure to detect drug users in the aviation industry,
the FAA believes that it is appropriate and necessary to
establish a comprehensive anti-drug program at this
time.” 53 Fed.Reg. 47025.

The regulations adopted by the FAA require employee
drug testing to be performed by every Part 121 and 135
certificate holder (generally, commercial air carriers,
both scheduled and unscheduled, carrying passengers or
cargo’), as well as each air traffic control facility.2 53
Fed.Reg. 47057-58 (App. I—definition of “employer’’).
The following employees must be tested: (a) flight crew
members; (b) flight attendants; (c) flight instructors or
ground instructors; (d) flight testing personnel; (e) air-
craft dispatchers; (f) maintenance personnel; (g) avia-
tion security or screening personnel; and (h) air traffic
controllers. 53 Fed.Reg. 47058 (App. I §III). Tests
must be performed for marijuana, cocaine, opiates, phen-
cyclidine (PCP) and amphetamines. Jd., § IV.

The regulations require testing of these employees on
a random basis. Jd., § V.C. To eliminate any supervisory
discretion in selecting the employees to be tested and to
avoid “potential bias toward and selective harassment
of an employee,” 53 Fed.Reg. at 8375, selection of em-
ployees to be tested must be made “using a random num-
ber table or a computer-based number generator that is
matched with an employee’s social security number, pay-

1 See 14 C.F.R. §§ 121.1, 135.1.

2 Air traffic control facilities operated by, or under contract with,
the FAA or te military are excepted. 53 Fed.Reg. 47057 App. I.
For the mos? pert, controllers at these facilities are covered by other
i drug testing programs.

| aati

6a

roll identification number, or any other alternative
method approved by the FAA.” 53 Fed.Reg. 47058,
§ V.C. After the first year of testing, employers must
conduct random tests at an annualized rate of not less
than 50 percent of the employees performing the func-
tions listed. Id., § V.C.(c) (2).°

The procedures under which the testing is to be done
are described in Procedures for Transportation Work-
place Drug Testing Program, 53 Fed.Reg. 47002 (Nov.
21, 1988) ; see also 53 Fed.Reg. 47056-61, and closely fol-
low the HHS drug-testing procedures for government
employees set forth at 53 Fed.Reg. 11,970 (April 11,
1988). Upon arriving at the “collection site,” the em-
ployee must present photographic identification or be
identified by a representative of the employer, and must
remove any outer garments, such as a coat or jacket.
The employee may choose to provide the required urine
specimen in a stall or otherwise partitioned area. The
toilet water is to be tinted with a blue dye to prevent
use of that water to adulterate the specimen, and a
monitor of the same gender as the employee must re-
main in the area, but gutside the stall. After receiv-
ing the specimen, the monitor must inspect it to ensure
that it is of proper volume, temperature, and color. The
monitor must then arrange, following specified chain-of- :
custody procedures, to ship the specimen to an HHS-
certified drug testing laboratory.

3 The regulations also require pre-employment testing, periodic
testing at the employee’s first medical examination for those em-
ployees required to take a Part 67 medical examination, post-accident
'testing, testing based on reasonable cause, and testing after return
to duty following a positive test or a refusal to test (return to
duty is authorized if the employee has completed drug rehabilitation,
and the medical review officer approves his return to work). 53
Fed.Reg. 47043-44, 47058, App. I § V. Petitioners do not challenge
these tests.

7a

The laboratory to which the specimen is sent must
perform an immunoassay test. If the specimen tests
positive, the test must be confirmed using gas chroma-
tography/mass spectrometry techniques. If the initial
positive test is confirmed, the employer’s Medical Re-
view Officer (who must be a qualified physician) de-
termines whether there is an “alternative medical ex-
planation” and in that connection must provide the em-
ployee with an opportunity to discuss the result and
submit any medical records regarding legally prescribed
medication. The employee may also demand a retest of
the original specimen at the original laboratory or an-
other HHS-certified laboratory.* In addition, there is an
absolute prohibition against the release of drug test re-
sults to third parties without the specific, written con-
sent of the employee.

Employees who test positive for prohibited drugs and
are unable to offer a satisfactory alternative explanation
must be removed from their positions, and may not re-
turn to duty except upon the recommendation of a Medi-
cal Review Officer or the Federal Air Surgeon.

B. This Litigation

Petitioners in this case include employees engaged in
various occupations within the commercial aviation in-
dustry who are subject to the FAA drug-testing rules,
the principal labor organizations in the industry, and an
organization of aviation employees and employers. Fol-
lowing the FAA’s issuance of the rules, timely petitions
for review were filed in this Circuit, the Fifth Circuit,
and the D.C. Circuit. Those petitions were then consoli-
dated in this proceeding. We have jurisdiction under 49
U.S.C.App. § 1486.

* The employee’s right to demand a retest is not part of the HHS
Guidelines for government agencies; it was added by DOT. 53
Fed.Reg. 47059, § VI.C.

8a

II. ANALYSIS
A. The Fourth Amendment Challenge

Petitioners’ primary contention is that the drug tests
required by the FAA are unreasonable searches in vio-
lation of the Fourth Amendment. Our disposition of this
issue is guided by the Supreme Court’s decisions in Na-
tional Treasury Employees Union v. Von Raab, ——
US. , 109 S.Ct. 1384, 103 L.Ed.2d 685 (1989), and
Skinner v. Railway Labor Executives Ass’n, —— US.
——, 109 S.Ct. 1402, 103 L.Ed.2d 639 (1989). In Von
Raab, the Court upheld a United States Customs Service
requirement that employees seeking transfers or promo-
tions to certain positions undergo urinalysis. In Skinner,
the Court upheld a Federal Railroad Administration pro-
gram requiring railroads to administer blood and urine
tests to train workers involved in major railroad acc:
dents, and permitting railroads to administer breath and
urine tests to employees who violate certain safety rules.

Von Raab and Skinner settle some of the threshold
questions in this case. First, drug testing performed by
private employers under compulsion of government regu-
lations constitutes governmental action subject to con-
stitutional restrictions. See Skinner, 109 S.Ct. at 1411-
12. Second, because “it is clear that the collection and
testing of urine intrudes upon expectations of privacy
that society has long recognized as reasonable,” urin-
alysis “must be deemed [a] search [] under the Fourth
Amendment.” Skinner, 109 S.Ct. at 1413; accord Von
Raab, 109 S.Ct. at 1390. Third, the usual Fourth
Amendment requirements of a warrant and probable
cause do not necessarily apply in the drug testing con-
text. Rather, when a search “serves special governmental
needs, beyond the normal need for law enforcement, it is
necessary to balance the individual’s privacy expectations
against the Government’s interests to determine whether
it is impractical to require a warrant or some level of

9a

individualized suspicion in the particular context.” Von
Raab, 109 §.Ct. at 1390.

In the present case it is clear that the FAA drug
testing requirements serve “special needs, beyond the
normal need for law enforcement” within the meaning
of Von Raab. As in Von Raab, the FAA rules specify
that “[t]est results may not be used in a criminal pros-
ecution of the employee without the employee’s consent.”
Id. Moreover, just as the Customs Service testing pro-
gram in Von Raab was designed “to deter drug use
among those eligible for promotion to sensitive positions
... and to prevent the promotion of drug users to those
positions,” id., so is the FAA’s program designed to de-
ter drug use among employees in safety-sensitive posi-
tions and to prevent the performance of safety-sensitive
functions by employees under the influence of narcotics.
We must therefore determine the constitutionality of the
FAA program by balancing the government’s interests
against the employees’ privacy interests.

In striking this balance, we take our primary guid-
ance from Von Raab, because we think that the random
testing at issue in this case is more closely analogous to
the facts of Von Raab than to those of Skinner. In Von
Raab, as in this case, the testing program did not re-
quire any level of individualized suspicion or the oc-
currence of any suspicion-triggering event; in Skinner,
on the other hand, testing was limited to those employees
involved in a train accident or safety rule violation. Ac-
cordingly, we proceed to consider whether this case can
be distinguished from Von Raab in a way that would
tip the balance against the constitutionality of the FAA’s
drug testing program.

In Von Raab, the Customs Service initiated a program
of testing employees for drugs as a condition of em-
ployment in positions that met any one of three criteria:
(1) direct involvement in drug interdiction or enforce-

10a

ment of related laws; (2) a requirement and the in-
cumbent carry a firearm; or (3) a requirement that the
incumbent handle “classified” material. See id. at 1388.
The drug tests followed procedures quite similar to the
FAA procedures at issue in this case. See id. at 1388-
89, 1394 n. 2. A union of federal employees challenged
the program as violative of the Fourth Amendment. The
Supreme Court upheld the testing program as applied to
the first two categories of employees listed above, and
remanded as to the third category (employees handling
classified information).

After concluding that the testing program invaded
reasonable expectations of privacy and that the tests were
motivated by special needs other than law enforcement,
the Court balanced the private and governmental inter-
ests at stake, and decided that the balance justified the
testing program. The Court reasoned that

[t]he Goverment’s compelling interests in prevent-
ing the promotion of drug users to positions where
they might endanger the integrity of the Nation’s
borders or the life of the citizenry outweigh the pri-
vacy interests of those who seek promotion to these
positions, who enjoy a diminished expectation of pri-
vacy by virtue of the special, and obvious, physical
and ethical demands of those positions.

Id. at 1897-98.

In reaching this conclusion, the Court rejected the pe-
titioners’ contention that there was insufficient evidence
of a drug problem in the Customs Service to justify sus-
picionless testing. The Court noted that drug abuse is
a pervasive social problem, and stressed that the testing

5 The Court found the record insufficiently clear to assess the
extent of the government’s interest in testing employees who hand!e
classified material, and therefore remanded for the court of appeals
“to clarify the scope of this category of employees subject to test-
ing.” Id. at 1397.

lla

program was aimed as much at deterrence as at detec-
tion. “In light of the extraordinary safety and national
security hazards that would attend the promotion of
drug users to positions that require the carrying of
firearms or the interdiction of controlled substances,” the
Court wrote, “the Service’s policy of deterring drug
users from seeking such promotions cannot be deemed
unreasonable.” Jd. at 1395.

The government interest in preventing drug use by
persons holding safety-sensitive positions in the aviation
industry is at least as compelling as the interest in pre-
venting drug use by Customs officers. Indeed, petitioners
concede that “the government has a strong interest in
assuring aviation safety and that the drug-related job-
impairment of any safety-sensitive aviation employee is
a basis for the most serious concern.” Reply Brief of
Petitioners at 15-16. Nonetheless, petitioners argue that
the FAA has failed to demonstrate a sufficiently high
level of drug use in the industry to justify its testing
program.

In our view, the evidence relied upon by the FAA is
stronger than the evidence relied upon by the Customs
Service in Von Raab. In Von Raab, the Service’s testing
scheme was not implemented in response to any perceived
drug problem among Service employees, and there was
evidence that only 5 employees of 3,600 tested positive
for drugs. Id. at 1394. As discussed earlier, the Su-
preme Court rejected the argument that this evidence
was insufficient to establish a substantial governmental
need, because of the deterrent purposes of the program
and the potential for serious harm. Id. at 1395.

In the present case, the FAA administrative record
included evidence that a number of pilots and other air-
line crew members had received treatment for cocaine
overdoses or addiction; that tests by companies in the in-
dustry had turned up instances of drug abuse by pilots

|

12a

and mechanics; and that drugs were present in the bod-
ies of pilots in two airplane crashes. Moreover, the
harm that can be caused by an airplane crash is surely
no less than the harm that might be caused by drug
impairment in the course of Customs Service employ-
ment. When viewed in this light, the need for the FAA’s
testing program equals, if not exceeds, that for the Cus-
toms Service program approved in Von Raab.

Petitioners also argue that the FAA testing program
intrudes more deeply on privacy interests than the pro-
gram approved in Von Raab.’ They point to the fact
that the FAA provides for unannounced (i.e., immediate)
testing, while the Customs Service program requires at
least five days’ notice; and that the FAA program is
random, while the Customs Service program is only ac-
tivated by certain events (ie. applying for certain
positions).

Although these factors add some weight to the “in-
vasion of privacy” side of the Fourth Amendment bal-
ance, they are insufficient to tip the scales against the
FAA drug testing program at issue here. The reason-
ing of the D.C. Circuit in Harmon v. Thornburgh, 878
F.2d 484 (D.C.Cir.1989), is instructive. In Harmon,
the court upheld (as to some employees) a Justice De-
partment testing plan that provided for random testing
and notice “on the same day, preferably within two

6 Although the FAA has made a showing of drug use by airline
employees, we note that nothing in Von Raab requires such a show-
ing. See Harmon v. Thornburgh, 878 F.2d 484, 487 (D.C.Cir.
1989) (“Nor is it necessary [under Von Raab] that a documented
drug problem exist within the particular workplace at issue.’’).

7 The petitioners have not urged that their expectation of privacy
is any less “diminished” than that of the Customs employees in Von
Raab. We therefore assume for the purposes of our decision that
this case is not distinguishable from Von Raab in that respect.

13a

hours, of the scheduled testing.” 878 F.2d at 486 (in-
terior quotation omitted). The court noted:

Certainly the random nature of the OBD testing
plan is a relevant consideration; and, in a particu-
lar close case, it is possible that this factor would
tip the scales. We do not believe, however, that this
aspect of the program requires us to undertake a
fundamentally different analysis from that pursued
by the Supreme Court in Von Raab.

Id. at 489. This is particularly true in light of the
FAA’s reasonable conclusion that random testing with-
out advance notice will prove to be a greater deterrent
than testing with advance notice.®

Finally, petitioners argue that the FAA plan grants
employers too much discretion. This argument is un-
persuasive. First, the strict randomness requirements
ensure that no employer will have discretion in deciding
which employees should be searched. Second, employers’
discretion as to how to structure their testing programs
will be limited by collective bargaining and the require-
ment that the FAA approve the plans of individual em-
ployers.®

In sum, we conclude that the Fourth Amendment is-
sue in this case cannot be meaningfully distinguished
from the Fourth Amendment issue addressed by the Su-
preme Court in Von Raab. We therefore reject petition-
ers’ constitutional challenge to the FAA drug testing
program.

8 For other decisions upholding random drug testing in the wake
of Von Raab, see American Fed. of Gov’t Employees v. Skinner, 885
F.2d 884 (D.C. Cir. 1989); National Fed. of Federal Employees
v. Cheney, 884 F.2d 603 (D.C. Cir. 1989); Thomson v. Marsh, 884
F.2d 113 (4th Cir. 1989).

® The FAA has stated that it will review the individual employer
programs to ensure that discretion is in fact sufficiently limited
under each plan. See 53 Fed. Reg. 47028.

l4a

B. The APA Challenge

Petitioners argue that the FAA failed to offer a satis-
factory explanation for its decision, and that the de-
cision was therefore arbitrary and capricious in viola-
tion of the Administrative Procedure Act, 5 U.S.C.
§ 706(2) (A). See Motor Vehicle Mfrs. Ass’n v. State
Farm Mutual Ins. Co., 463 U.S. 29, 43, 103 S.Ct. 2856,
2866, 77 L.Ed.2d 448 (1983) (agency must articulate
a satisfactory explanation for its action). In particular,
petitioners question the FAA’s decision to reject the rec-
ommendation of the National Transportation Safety
Board that the FAA rely on non-random forms of drug
testing.

This argument is without merit. The FAA, contrary
to petitioners’ contention, explained specifically why it
chose to require random testing, reasoning that there
was more evidence supporting the efficacy of random
testing programs than of non-random programs. See 53
Fed.Reg. 47034, 47035, 47048. Its decision that safety
concerns outweighed privacy concerns in this context was
a reasonable, if controversial, decision, and cannot be
overturned as arbitrary and capricious.

Petitioners also argue that the FAA’s decision to in-
clude flight attendants within the testing requirements
is inconsistent with prior FAA decisions denying peti-
tions of flight attendants to establish safety rules limit-
ing their on-duty time. The duty time decisions, how-
ever, do not stand for the proposition that impairment
of flight attendants’ performance is never a public safety
consideration. Rather, the FAA concluded that, on the
evidence before it, there was no correlation between flight
attendant duty time and risk to passengers. We see no
conflict between the duty time decisions and the inclu-
sions of flight attendants in the drug testing program.”

10 Although petitioners do not directly contend in this proceeding
that flight attendant positions are not safety-sensitive, it is none-

ee ee oe eet

15a

Accordingly, we hold that the FAA acted within its au-
thority in requiring random drug testing of flight at-
tendants.

III. CONCLUSION

For the foregoing reasons, we affirm the decision of
the Federal Aviation Administration.

theless worth noting that the administrative record adequately sup-
ports the FAA determination that such positions are, in fact,
safety-sensitive. Flight attendants must perform important safety
functions in the event of emergencies, and are also routinely re-
sponsible for ensuring that luggage is safely stored and the air-
plane doors properly closed and locked prior to departure.

16a
APPENDIX B
DEPARTMENT OF TRANSPORTATION
Federal Aviation Administration
14 CFR Parts 61, 63, 65, 121, and 135

[Docket No. 25148; Amdt. Nos. 61-81, 63-25,
65-32, 121-201 and 135-28]

RIN 2120-AC33

Anti-Drug Program for Personnel Engaged in
Specified Aviation Activities

AGENCY: Federal Aviation Administration (FAA),
DOT.

ACTION: Final rule.

SUMMARY: This final rule sets forth regulations to re-
quire domestic and supplemental air carriers, commercial
operators of large aircraft, air taxi and commuter oper-
ators, certain commercial operators, certain contractors
to these operators, and air traffic control facilities not op-
erated by the FAA or the U.S. military to have an anti-
drug program for employees who perform sensitive safety-
or security-related functions. A special provision has been
added to the rule that provides that the final rule does
not apply to any person where compliance with the final
rule would violate the domestic law or policy of another
country. Testing under the rule will be conducted by an
employer prior to employment, periodically, randomly,
after an accident, based on reasonable cause, and after
an employee returns to duty to perform a sensitive safety-
or security-related function for an employer. The final
rule also will require that an employer provide EAP edu-
cation and training services to employees and supervisors.

17a

The rule is necessary to prohibit an employee from, per-
forming a sensitive safety- or security-related function
for an employer while that employee has a prohibited drug
in his or her system or if that employee has used drugs
as evidenced by a drug test showing the presence of drugs
or drug metabolites. The rule is intended to ensure a
drug-free aviation workforce and to eliminate drug use
and abuse in commercial aviation.

EFFECTIVE DATE: This final rule is effective on De-
cember 21, 1988.

FOR FURTHER INFORMATION CONTACT: Dr.
Robert S. Bartanowicz, Acting Deputy Director, Office of
Rulemaking (ARM-1), Federal Aviation Administration,
800 Independence Avenue SW., Washington, DC 20591;
telephone (202) 267-9679.

SUPPLEMENTARY INFORMATION:
Availability of Final Rule

Any person may obtain a copy of this final rule by
submitting a request to the Federal Aviation Administra-
tion, Office of Public Affairs, Attn: Public Inquiry Center
(APA-230), 800 Independence Avenue SW., Washington,
DC 20591, or by calling (202) 267-3484. Requests must
include the amendment number identified in this final
rule. Persons interested in being placed on a mailing
list for future rulemaking actions should request a copy
of Advisory Circular 11-2A, Notice of Proposed Rulemak-
ing Distribution System, which describes the application
procedure.

Background

On December 4, 1986, the Federal Aviation Adminis-
tration (FAA) issued an advance notice of proposed rule-
making (ANPRM) (51 FR 44432; December 9, 1986)
entitled “Control of Drug and Alcohol Use for Personnel
Engaged in Commercial and General Aviation Activities.”

18a

The ANPRM invited comment from the public on drug
and alcohol abuse by personnel in the aviation industry
and the options available to the FAA for regulatory or
other action in the interest of aviation safety. The FAA
received over 650 written comments in response to the
issues raised in the ANPRM.

On March 3, 1988, the FAA issued a notice of proposed
rulemaking (NPRM) (53 FR 8368; March 14, 1988) en-
titled ‘‘Anti-Drug Program for Personnel Engaged in Spe-
cified Aviation Activities.” The NPRM set forth an anal-
ysis of the comments received on the ANPRM and pro-
posed regulations for public comment. The FAA received
over 260 written comments on the proposals contained in
the NPRM.

The FAA also held a series of public hearings on the
regulations proposed in the NPRM. These hearings were
held on June 2, 1988, in Washington, DC; June 7, 1988,
in Denver, Colorado; and June 9, 1988, in San Francisco,
California. Each of the hearings was recorded by a court
reporter. The transcript of each hearing and any state-
ments or other material, submitted to the hearing panel
during the hearings, have been placed in the public docket.
This material also has been reviewed in the development
of the final rule.

Current Rules. The FAA’s comprehensive anti-drug pro-
gram is one action in a long history of actions to combat the
use of drugs and alcohol in the aviation industry. The focus
of the majority of these actions has been on commercial avi-
ation personnel, particularly the cockpit and cabin crew.
For example, pilots, flight attendants, flight engineers, and
flight navigators may not act as a crewmember of a civil
aircraft within eight hours after drinking an alcoholic
beverage; while under the influence of alcohol; with 0.04
percent, or more, alcohol in their blood; or while using
any drug that affects their faculties in any way contrary

eta to hl areal

OE Nn ns AL ects Heee so

tend

hela sr Nabe 0 ae at os

a RA tt CeO ie Nad Dt Bhs ares Stet SIE ERE iin CA wept

19a

to safety. Also, crewmembers may be tested in the con-
text of receiving medical care immediately after an acci-
dent. When there is a reasonable basis to suspect that
one of these individuals has violated any of the above
restrictions, these crewmembers must furnish, to the FAA,
the results of any test taken within four hours of acting,
or attempting to act, as a crewmember that indicates the
presence of alcohol or any such drug in the person’s sys-
tem. Moreover, pilots, flight attendants, flight engineers,
and flight navigators are required to submit to a test to
indicate the percentage of alcohol in the blood when re-
quested by a law enforcement officer who suspects that a
crewmember may have violated a State or local law gov-
erning the operation of an aircraft while under the in-
fluence, or impaired by, drugs or alcohol.

The FAA may deny an application for a certificate or
rating for up to one year, or may suspend or revoke an
existing certificate or rating, in the case of any pilot,
flight engineer, or flight navigator who has been convicted
of violaiing a Federal or State law relating to drug traf-
ficking or possession; who has violated the proscriptions
described above; who has refused to furnish the results of
any test that would indicate the presence of alcohol or
drugs taken within four hours of acting, or attempting to
act, as a crewmember; or who has refused to submit to
an alcohol test requested by a law enforcement officer in-
vestigating violations of State or local laws. The FAA
also may deny an application for a certificate or rating
for up to one year, or may suspend or revoke an existing
certificate or rating, in the case of any air traffic control
tower operator, aircraft dispatcher, mechanic, repairman,
or parachute rigger who has been convicted of a violation
of a Federal or State law relating to drug trafficking or
possession.

The Aviation Drug-Trafficking Control Act of 1984,
which added language to sections 602 and 609 of the Fed-
eral Aviation Act of 1958, mandates that the FAA take

20a

certain actions regarding airmen involved in drug traffick-
ing activities. The Administrator is required to revoke
the airman certificate of any airman who has been con-
victed of violating any Federal or State law relating to a
controlled substance, other than simple possession, if an
aircraft was used in, or was used to facilitate, the com-
mission of the offense and the person served as an airman,
or was onboard the aircraft, in connection with the com-
mission of the offense. The Administrator has no discre-
tion to review the conviction for the substantive offense.
Under the 1984 legislation, the Administrator was pro-
hibited from reissuing a certificate to that airman for
up to five years but could reissue a certificate after an
absolute minimum of one year, in certain extremely lim-
ited circumstances, if revocation was excessive and con-
trary to the public interest. As part of the Federal Avia-
tion Administration Drug Enforcement Assistance Act of
1988, Congress amended sections 602 and 609 of the FAA
Act, among other amendments to the Act, in October 1988.
The statutory language now provides that the Adminis-
trator shall not issue an airman certificate to any person
whose certificate has been revoked for aviation drug
trafficking activities unless the airman is acquitted of
the offense, a conviction upon which revocation is based
is reversed on appeal, or the Administrator determines
that issuance of an airman certificate will facilitate law
enforcement efforts after a request from a Federal or
State law enforcement official. The final rule requiring a
comprehensive anti-drug program for employees in com-
mercial aviation is consistent with these previous actions
taken by the FAA.

The FAA’s commitment to a drug-free workforce also
applies to its own employees. The Department of Trans-
portation began random drug testing of DOT employees
in safety- and security-sensitive functions in September
1987. The Secretary’s goal is to establish and maintain
a drug-free workplace as intended by Executive Order
12564 and as directed by Presidential memorandum dated

aaa ieadeninaaeinemmmeiaieeeieel

2la

October 4, 1986. It is the opinion of the Department of
Transportation that random drug testing is the most
effective means of determining the presence of drugs or
drug metabolites that may adversely affect an employee’s
performance of safety- or security-sensitive job functions.
Pursuant to the Department’s program, an employee of
the Department will be removed from Federal service un-
der several circumstances: refusal to enter or to suc-
cessfully complete a drug rehabilitation or abatement pro-
gram; repeat usage of drugs; refusal to provide a urine
specimen for drug testing; adulteration or substitution
of a urine specimen; on-duty use of illegal drugs; or
a determination that a DOT employee has engaged in
illegal drug trafficking.

In order to ensure that aviation safety is not compro-
mised by a failure to detect drug users in the aviation
industry, the FAA believes that it is appropriate and
necessary to establish a comprehensive anti-drug program
at this time.

Existing Industry Programs. As part of their com-
ments to the ANPRM and the NPRM, many employers
note that they have implemented drug testing programs
or employee rehabilitation programs. For example, al-
though their drug testing programs were not specifically
described, Martin Aviation implemented a drug testing
program in February 1987 and Suburban Airlines has re-
quired preemployment drug testing of flight crew appli-
cants for over a year. Federal Express Corporation cur-
rently conducts preemployment testing of all applicants
and “reasonable suspicion testing” of all employees.

Tramco, Ine. is a certificated repair station employing
over 600 individuals and repairing over 100 aircraft per
year. Tramco instituted a drug testing and counseling
program “several years ago” and believes that the pro-
gram yields substantial benefits to both employees and
employers. Tramco tests all applicants for jobs and con-
ducts tests based on probable cause. Tramco’s tests based

22a

on probable cause are triggered by reports of employee
drug use, employee attendance patterns that may suggest
a drug problem, accidents, and observation by super-
visors. A Tramco employee who tests positive for drugs
is suspended for a minimum of one week and may not
return to work until a drug test shows no evidence of
drug use. Tramco estimates that, consistent with general
statistics, 20 percent of its workforce has had some in-
volvement with controlled substances. As of the time of
its comment to the NPRM, Tramco identified 10 percent
of its employees as individuals who had used drugs.

Rocky Mountain Helicopters, Inc. implemented a drug
testing program for its employees in July 1986. Rocky
Mountain Helicopters tests all pilots, mechanics man-
agers, and others who can affect aviation safety using
preemployment, random, probable cause, and postaccident
testing. Rocky Mountain Helicopters does not pay an em-
ployee’s rehabilitation costs but will consider rehiring any
employee who completes an approved rehabilitation pro-
gram. Petroleum Helicopters, Inc. began a preemploy-
ment and periodic testing program in 1982 and supports
mandatory drug testing. Petroleum Helicopters denies
employment to any applicant, and discharges any em-
ployee, who tests positive in a drug test. Petroleum Heli-
copters does not concur with the proposal to provide a
rehabilitation opportunity to employees on the basis that
an employer should not accept the risk of repeated illegal
drug use among maintenance or flight personnel. -

The FAA believes that the comprehensive anti-drug
program, promulgated by this final rule, is not a novel
concept. In light of the FAA’s long history of regulatory
action in the area of drug use in aviation and the sig-
nificant number of industry drug testing programs cur-
rently implemented by aviation employers, the FAA be-
lieves that the agency is justified in requiring the com-
mercial aviation industry to implement similar compre-
hensive anti-drug programs.

23a

Discussion of Comments
General Overview of the Major Issues

The FAA received 261 comments in response to the
NPRM. The FAA considered all timely-filed comments
submitted in response to the NPRM and the testimony
of 20 individuals who presented statements at the three
public hearings held by the FAA. During the public
hearings, the Secretary of Transportation, James H.
Burnley, requested information from several individuals
who presented statements at the hearings. The comment
period for the NPRM closed on June 13, 1988. In order
to accommodate the individuals who submitted supple-
mental information pursuant to the Secretary’s request,
the FAA also considered comments that were submitted
as late as July 1, 1988.

There were several major themes presented by the
commenters. Many commenters focus on the lack of evi-
dence of significant drug use or drug abuse in the avia-
tion industry. The commenters particularly stress this
point with respect to the cockpit crew based on age, in-
come, managerial supervision, close working relationships
with peers, periodic medical exams to determine fitness
for duty, and professionalism of the crew. Based on the
lack of evidence, these commenters conclude that estab-
lishment of a drug testing program is unwarranted and
unconstitutional. Regardless of the amount of evidence,
the majority of commenters agree with the FAA’s assess-
ment that drug use and substance abuse have no place in
the aviation environment. Some commenters note that
the FAA’s anti-drug stance is commendable, but the true
issue is the type of program that evolves from that
stance. Many commenters support the FAA’s efforts to
develop a comprehensive anti-drug program that would
achieve a drug-free commercial aviat‘on workforce and
agree that a program to achieve a drug-free aviation
environment is beneficial.

24a

There is substantial, although not universal, support
for a drug testing program using state-of-the-art urine
testing. The gas chromotography/mass_ spectrometry
(GC/MS) method, approved by the Department of Health
and Human Services (DHHS), is recognized by the com-
menters as the most accurate method of analysis for the
presence of drugs or drug metabolites in urine if rigorous
collection and analysis procedures, such as those contained
in the DHHA mandatory guidelines, are followed. (As
discussed in detail elsewhere in this preamble, the Depart-
ment of Transportation is publishing “Procedures for
Transportation Workplace Drug Testing Programs”
which are adopted in this final rule in lieu of the DHHS
guidelines. These DOT-wide procedures closely resemble
the DHHS guidelines and are used-because the DHHS
guidelines are not drafted for application by entities
other than Federal agencies.) While some concerns were
raised about the testing procedures, these concerns gen-
erally involve drug testing programs and procedures in
the early 1980s that did not embody the critical safe-
guards of a properly-administered testing program.

Certain types of testing proposed in the NPRM receive
significant support by the commenters. These types of
testing include preemployment testing and postaccident
testing. Periodic testing and testing based on reasonable
cause received substantial support from the commenters.
Some support for testing based on reasonable cause is
predicated on traditional constitutional standards that
apply to a search of the person.

There is significant and strongly-held opposition to
random testing. However, the FAA’s drug testing pro-
gram, including random testing as a critical element, is
supported by some commenters. The objections to random
testing are based on legal or constitutional issues, pri-
vacy issues, privacy issues, and the invasive nature of
random testing based on personal grounds, cost issues,
and the absence of a demonstrated need for a compre-

25a

hensive testing program assuming a low level of drug use
in the industry.

Of those commenters who address the issue, there is
agreement that the complexity, cost, and operational im-
pact burdens of the rule would be significantly greater
on small entities in the aviation industry. Finally, the
commenters express significantly different opinions in the
area of employee assistance programs (EAP). The pri-
mary differences surround the issues of the circumstances
under which an employee is offered an opportunity for
rehabilitation and the entity or individual who is respon-
sible for payment of rehabilitation costs. Several major
air carriers have already addressed this issue through
insurance coverage or by labor-management agreement.
However, even some of these organizations, although sup-
portive of EAPs, oppose a broad, Federally-mandated
EAP requirement. Labor organizations clearly support
expansive EAP opportunities and services. Small entities
oppose EAP requirements on many grounds, including
cost and possible negative coworker attitudes exhibited
toward rehabilitated employees.

The commenters differ regarding the method of achiev-
ing a drug-free aviation workforce and the manner in
which the FAA would be involved in any program. The
primary differences arise regarding the type and scope
of testing used to identify sensitive safety- or security-
related personnel who use drugs and the choices offered
to those individuals who are identified as drug users.

Labor Unions and Organizations Representing Em-
ployees. In general, unions or organizations representing
employees in aviation oppose the comprehensive manda-
tory drug testing proposed in the NPRM. Labor unions
and employee organizations favor EAP and broad re-
habilitation rights for all employees. These organizations
oppose random drug testing but, with some qualifications,
these organizations see a role for preemployment testing,

26a -

postaccident testing, testing based on reasonable cause,
and testing during and after rehabilitation to monitor an
individual’s progress.

The International Association of Machinists and Aero-
space Workers (IAM) opposes any industry-wide drug
and alcohol testing until hard evidence of an industry
drug problem that jeopardizes aviation safety is substan-
tiated and documented. The Independent Union of Flight
Attendants (IUFA) opposes all forms of mandatory drug
testing of employees. The Independent Federation of
Flight Attendants (IFFA) objects generally to drug test-
ing as unwarranted governmental intervention into labor-
management relations but would support preemployment
screening and postaccident testing if reasonable cause for
such testing can be objectively illustrated. IFFA objects
specifically to random testing in any form as unconstitu-
tional and contrary to labor law. IFFA believes that the
focus of any drug testing program should be limited to
impairment on the job and states that no currently avail-
able testing procedure can determine drug impairment on
the job. The Asscciation of Flight Attendants (AFA)
believes that drug testing of flight attendants is not
warranted. However, AFA and the Association of Pro-
fessional Flight Attendants (APFA) support preemploy-
ment testing of applicants seeking jobs in the industry if
that testing is not used to discriminate against applicants
on the basis of disabilities unrelated to drug use. AFA
also would not oppose postaccident testing of pilots or
probable cause drug testing of employees who are under
the influence of drugs if these samples were collected by
an FAA inspector. APFA opposes random testing, post-
accident testing absent individualized suspicion, and test-
ing based on reasonable cause as proposed. The Flight
Engineers’ International Association (FEIA) opposes all
testing except in the case where probable cause exists to
believe that an employee is impaired by drugs; in order
to protect employees from harassment, FEIA states that

OE en eee

27a

any determination to test an employee based on probable
cause for impairment should be reviewed by a neutral
party. The Teamsters Union could support preemploy-
ment screening; testing based on reasonable suspicion to
believe that an employee’s actual or current impairment
has, or is, affecting job performance or workplace safety;
periodic testing to maintain medical certification; and
testing after an accident or a “near miss” if there is a
reasonable basis to suspect that human error may have
been a causal factor.

The Air Line Pilots Association (ALPA), representing
41,000 pilots employed by 44 large and small airlines, is
firmly opposed to all forms of drug and alcohol abuse by
airline personnel. ALPA primarily is opposed to random
and periodic testing based on their belief that these tests
are offensive, ineffectual, unjustified, and unconstitu-
tional. ALPA believes that if there is drug use among
commercial pilots, the incidence of drug use would be less
than 0.5 percent. On this basis, ALPA asserts that wide-
scale random testing of the relatively small aviation popu-
lation will result in a significant number of false-positive
test results. ALPA does not oppose testing prior to em-
ployment, testing after an accident, testing in circum-
stances where there are reasonable grounds to suspect
drug use, and testing to monitor rehabilitation.

ALPA believes that the approach to the drug abuse
problem articulated in the NPRM is inappropriate.
ALPA instead urges the FAA to consider an approach
similar to the Human Intervention Motivation Study
(HIMS) program developed to identify and treat alco-
holism among pilots. The key elements of the HIMS
program are education, peer involvement, intervention,
confrontation, and rehabilitation. Although the HIMS
program has focused on treatment of pilots who demon-
strate a problem with alcohol, ALPA sponsored a HIMS
drug abuse training program in November 1987 which
the FAA attended.

28a

Labor and employee organizations also strongly sup-
port limitations on an employer’s ability to exclude any
employee from an opportunity for rehabilitation and limi-
tations on an employer’s ability to discharge an em-
ployee. Most organizations, including IUFA, IFFA, AFA,
and APFA, strongly support regulations that would re-
quire an employer to establish and participate in compre-
hensive, nonpunitive EAP services established by collec-
tive bargaining or negotiation and available to all em-
ployees. ALPA agrees that any regulations should clearly
recognize that unions have collective bargaining rights
under Federal labor laws; ALPA suggests that any anti-
drug regulations promulgated by the FAA should ensure
that the regulatory requirements do not interfere or over-
ride the union’s collective bargaining rights. FEIA sup-
ports EAP services, mandatory for each carrier and paid
for by the carrier, for rehabilitation of all employees re-
gardless of the circumstances that precipitated a drug
test. IAM suggests that FAA regulations should be
guidelines, applicable only to carriers who have a docu-
mented substance abuse problem affecting aviation safety,
that stress education, prevention, rehabilitation, and pro-
tection of an employee’s privacy.

Employers and Organizations Representing Employers.
Most employers support mandatory drug testing of em-
ployees and limitations on an employees opportunity for
rehabilitation. Part 121 and Part 135 certificate holders
do not express the same opinions regarding the proposals
in the NPRM. The general views held by Part 121 cer-
tificate holders are characterized by the comments sub-
mitted by the Air Transport Association of America
(ATA). ATA supports the FAA’s comprehensive drug
testing program and favors an opportunity for rehabili-
tation only for those employees who volunteer for re-
habilitation. In the area of EAP services, Part 121 cer-
tificate holders generally favor flexibility and latitude for
an employer to design a company EAP. American Air-

- he Lee ee

29a

lines, however, favors industry-wide standard EAP re
quirements.

Most Part 135 certificate holders and small aviation
businesses object to the drug testing requirements pro-
posed in the NPRM. The Regional Airline Association
(RAA), which represents many Part 135 certificate hold-
ers, opposes random testing; RAA also suggests that the
random selection rate be set at a rate less than the maxi-
mum 125 percent rate proposed in the NPRM if the FAA
mandates a random testing requirement. The Primary
objection of Part 135 certificate holders and small busi-
nesses is to the proposed requirement to offer an oppor-
tunity for rehabilitation to an employee. These organiza-
tions oppose mandated rehabilitation because of the eco-
nomic burden that would be imposed on a small operator.
The National Air Transport Association (NATA) sug-
gests, in its June 2, 1988 testimony, that Part 135 cer-
tificate holders employing 100 or fewer covered employees
should be exempted from all requirements of the proposed
anti-drug program.

Grace Flying Service, Inc., a Part 135 certificate holder
conducting single-engine air taxi services, flight instruc-
tion, and aerial application services, opposes drug testing
of employees. Grace Flying Service strenuously objects
to any drug tests, whether scheduled or random, and
would be reluctant to test its employees even if testing is
mandated by the FAA.

The National Business Aircraft Association (NBAA)
concurs with the FAA’s anti-drug program with certain
reservations. NBAA primarily is concerned about the
constitutionality of random drug testing and the FAA’s
reliance on laboratory testing results that may be un-
reliable in detecting drugs or drug metabolites proposed
to be analyzed in the NPRM.

Individual Commenters. The FAA received 170 com-
ments from individuals. The majority of these individ-

30a

uals are pilots employed by major airlines and self-
employed pilots who would be subject to the requirements
of the proposed rule. The FAA also received comments
from general aviation pilots and individuals who are not
employed in the commercial aviation industry. The vast
majority of the individual commenters oppose the drug
testing requirements of the proposed rule based on con-
stitutional objections, failure of the FAA to demonstrate
a drug problem in the aviation community, and perceived
inaccuracies of drug testing collection and analysis. A
minority of individual commenters generally support the
FAA’s anti-drug proposals and primarily support the
testing requirements. These individuals are private citi-
zens or consumers who base their support on the need to
ensure that aviation personnel are drug free, particularly
on the job. The strongest individual support is expressed
by letters from the family and friends of a passenger
who was killed in the crash of Continental Air Express
Flight 2286 near Durango, Colorado. The comments from
the family and friends of the deceased passenger urge
the FAA to do everything within its statutory authority
to prevent a similar tragedy in the future.

Specific Issues

Discussion of the constitutional! issues regarding ran-
dom and periodic drug testing. A number of commenters
have questioned the constitutionality of drug testing pro-
grams for aviation personnel. Although the state of the
case law is still evolving in rapid fashion and no defini-
tive Supreme Court resolution of many relevant and com-
plex issues has been achieved, the FAA feels confident
that testing required under this rule will pass constitu-
tional scrutiny. The FAA recognizes that there are legit-
imate and significant constitutional concerns surrounding
drug testing in general and random drug testing as a
specific component of drug testing. The FAA acknowl-
edges the current widescale litigation and apparent dis-
parate judicial opinions on drug testing programs.

ee ee ‘ mits tem" ob

ey

Seat ce Rete a ate ie see ade

3la

FAA Response. The principles of the Fourth Amend-
ment to the U.S. Constitution are paramount in scrutiniz-
ing the fundamental legality of many drug testing pro-
grams. As a threshold legal matter, the Fourth Amend-
ment applies to “searches” conducted or mandated by the
government and protects individuals against “unreason-
able searches and seizures.” Action of a private party
does not constitute State (or Federal) action unless there
exists a close nexus between the state and the action
in question. Jackson v. Metropolitan Edison, 419 US.
345 (1974); Moose Lodge No. 107 v. Irvis, 407 U.S. 162
(1972).

Assuming that the drug testing programs called for
under the final rule do implicate the government, a second
issue then arises concerning whether urine tests under
these programs are “searches” within the meaning of the
Fourth Amendment. Although most courts to address the
issue to date have ruled that toxicological testing of em-
ployees for the purpose of determining fitness for duty
is a search within the meaning of the Fourth Amendment,
the issue is not entirely settled. See Wyman v. James,
400 U.S. 309, 317-338 (1971) (government welfare case-
worker’s “home visit” as a precondition for assistance
payments is not a Fourth Amendment search). See also,
Lovvorn v. City of Chattanooga, 846 F.2d 1539, 1553-
1554 (6th Cir. 1988) (Guy, J., dissenting), panel decision
vacated and rehearing en bane ordered, (August 3,
1988) ; National Treasury Employees Union v. von Raab,
808 F.2d 1057, 1060, 1062 (5th Cir. 1987) (Higgin-
botham, J., concurring). Cf. Mack v. United States,
F.B.I., 814 F.2d 120, 125 n.2 (2nd Cir. 1987).

Also assuming, arguendo, that urine tests of aviation
personnel for illegal drugs are “searches” within the
meaning of the Fourth Amendment, it is clear that while
searches ordinarily must be conducted pursuant to a war-
rant issued on probable cause grounds, such a require-
ment is not always necessary. Almeida-Sanchez v. United

32a

States, 4138 U.S. 266, 277 (1973) (Powell, J., concur-
ring). Where, for example, “* * * the burden of obtain-
ing a warrant is likely to frustrate the governmental
purpose behind the search * * *,” [Camera v. Municipal
Court, 387 U.S. 528, 583 (1967)], the Supreme Court
has routinely held that a warrant is not required by the
Fourth Amendment. See e.g., Griffin v. Wisconsin, 107
S.Ct. 3164, 3167 (1987); New Jersey v. T.L.O., 469 U.S.
325, 340 (1985). The Supreme Court has likewise found
that the probable cause standard is inappropriate where
it would defeat the purpose that the search is designed to
achieve. See e.g., New Jersey v. T.L.0., 469 U.S. at 340-
342; O'Connor v. Ortega, 107 S.Ct. 1492, 1501-1502
(1987) (plurality opinion) (upholding the search of a
public employee’s office for work-related noninvestigatory
reasons on less than probable cause grounds); United
States v. Martinez-Fuerte, 428 U.S. 548, 560-561 (1976)
(footnotes omitted) (while “* * * some quantum of indi-
vidualized suspicion is usually a prerequisite to constitu-
tional search or seizure,] * * * the Fourth Amendment
imposes no irreducible requirement of such suspicion’’).

Rather, “[t]he fundamental command of the Fourth
Amendment is that searches and seizures be reasonable
** *” New Jersey v. T.L.0., 469 U.S. at 340. In deter-
mining the reasonableness of a search, the Supreme Court
has repeatedly stressed the importance of the facts par-
ticular to the search while acknowledging that the test
of reasonableness “* * * is not capable of precise defini-
tion or mechanical application.” Bell v. Wolfish, 441 U.S.
520, 559 (1979). In analyzing a drug testing program,
«* * * what is reasonable depends on the context within
which a search takes place.” New Jersey v. T.L.O., 469
U.S. at 337.

In scrutinizing whether particular searches comport
with the Fourth Amendment, courts have adopted a bal-
ancing test. In general, to support a claim that a search
of an individual or the individual’s property is reason-

ae ee

te al ae nn er ee

wet.

to Dee me Ladi —

~
: af
f
Fs
x
A
-
>
&

127a

accidents discussed previously. The information does not
reveal any significant patterns that would assist the
FAA’s estimates of costs and benefits of the proposals
and, in any event, this information is not generally rep-
resentative of personnel who are not pilots but who are
subject to the requirements of the rule. For these rea-
sons, the FAA believes that it is appropriate to use the
national NIDA study information to estimate the potential
costs of the rule because it more accurately reflects the
broad population of employees who would be tested pur-
suant to a comprehensive drug testing program.

Economic Summary

In accordance with the requirements of Executive Order
12291, the FAA reviewed the cost impact and benefits of
this final rule. Cost factors were obtained from informa-
tion in the public docket including comments received
during the FAA’s public hearings. Additional data were
furnished by air carrier trade associations, public insti-
tutions, and major chemical and drug testing laboratories.
This rulemaking does not meet the criteria of a “major”
rule under Executive Order 12291 because it is not likely
to have an annual effect on the economy of $100 million
or more. A summary of the FAA’s estimates of the costs
and benefits is provided below. However, because the
rulemaking is a costly undertaking, the FAA considers
the final rule to be a “major” rule under Executive Order
12291. For this reason, the FAA prepared, and placed in
the docket, a Regulatory Impact Analysis of the final
rule. In addition, because the rule involves issues of sub-
stantial interest to the public, the FAA determined that
the rulemaking is significant under the Regulatory Pol-
icies and Procedures of the Department of Transportation
(44 FR 11034; February 2, 1979).

Costs. The FAA estimated that the requirements of
the final rule, over the 10-year period from 1990 to 1999,
will cost approximately $240.3 million in 1987 dollars (an

128a

average of $24.0 million per year) or approximately
$135.2 million discounted over that 10-year period. The
discounted cost includes (rounded to the nearest million)
$97.1 million for random testing; $6.2 million for periodic
testing, postaccident testing, testing based on reasonable
cause, and return-to-duty testing; $8.6 million for pre-
employment testing; $10.6 million for blind samples sub-
mitted to laboratories; $10.3 million for EAP education
and training cost; and $2.4 million for costs associated
with preparation and submission of an employer’s anti-
drug program.

Costs of postaccident testing, testing based on reason-
able cause, and return-to-duty testing are included as part
of periodic testing costs. The FAA used one-half of one
percent of the estimated population tested annually as the
number that will be tested under one of these three cir-
cumstances. The analysis of these costs is set forth in
the full Regulatory Impact Analysis (Exhibit A) included
in the public docket.

The final rule will affect 149 entities that hold Part 121
certificates, 3,614 entities that hold Part 135 certificates
providing scheduled and on-demand service, and con-
tractors who provide services to those certificate holders.
The rule also will affect an undetermined number of en-
tities engaged in operations listed in §135.1(b) for com-
pensation or hire. The FAA has been unable to determine
the exact number of these organizations due to the highly
diversified and multipurpose nature of their operations.
For purposes of analyzing the cost impact of the final
rule on these entities, the FAA estimated that approx-
imately 1,500 entities, the same number as renair stations,
are engaged in operations listed in § 185.1(b) for com-
pensation or hire. Based on these estimates, the FAA
estimated that 538,000 persons will be subject to drug
testing in 1991 pursuant to the requirements of the final
rule.

129a

The FAA estimated that the cost of an initial screening
test for the presence of drugs or drug metabolites will be
$25 per test. The FAA expects that 12.5 percent of initial
screening tests will require confirmation testing in accord-
ance with the guidelines and standards contained in Ap-
pendix 1 to Part 121. Of the total initial screening tests,
7.5 percent are expected to be confirmed as true positives;
5.0 percent are expected to result in false positive test
results after confirmation. The remainder are not ex-
pected to be confirmed as positive either because the
specimen failed to meet the minimum threshold to be sci-
entifically considered as positive, or because the specimen
did not show the presence of drugs or drug metabolites.
Confirmation tests are estimated to cost $35 per test. The
FAA notes that an employer can realize substantial sav-
ings by contracting with a drug testing laboratory for a
fixed price that includes the cost of initial screening tests
and confirmation tests rather than paying for these tests
separately. For example, the Coast Guard currently pays
a single, fixed price of $21 for screening tests and any
resulting confirmation tests under a single contract with
a drug testing laboratory.

The FAA estimated that a screening test will require
15 minutes of a person’s time to provide information for
chain-of-custody forms and to provide a urine sample for
drug testing. Thus, the FAA included a factor equal to
25 percent of an average, fully allocated, hourly wage
for each occupational group covered by the final rule. The
FAA also assumed that affected persons will provide urine
samples for testing while on duty. The FAA included $35
per test as an administrative cost to cover, among other
things, collection of specimens, reporting and recordkeep-
ing, and chain-of-custody procedure costs. The FAA recog-
nizes that these costs can vary significantly depending on
a number of variables. For example, specimens may be
collected in a medical setting (i., in a hospital or a
clinic, in the presence of medical doctors, nurses, medical

130a

technicians). Collection of specimens in a medical setting
is not required by this rule. Less expensive settings and
nonmedical personnel trained for specimen collection may
be used by the aviation industry. Collection sites may
be either centrally located or dispersed throughout remote
geographical locations. DOT’s drug testing program and
the FAA’s periodic drug testing program illustrate the
cost variations associated with specimen collection. DOT
uses a contractor to collect specimens at various, dis-
persed locations throughout the country. DOT pays an
average of $123 for each specimen collected. Specimens
collected as part of the FAA periodic testing program are
collected by aviation medical examiners. Collection costs
for periodic tests range from $10 to $45 per specimen.
The FAA considered these costs when estimating the ad-
ministrative costs of the final rule. After consideration
of the cost variations, the estimated administrative costs
are representative of the costs expected in the aviation
industry. The FAA increased the administrative costs
contained in the NPRM on the basis of information sub-
mitted by commenters. The FAA believes that the avia-
tion industry will find the most economical method of
sample collection and will do so at costs that most closely
mirror the costs charged to the FAA by aviation medical
examiners for collection of specimens for periodic testing.

In the case of most postaccident testing, based on rea-
sonable cause, and testing after return to duty triggered
by refusal to submit to a test or failure of a previous
drug test, the FAA assumed that collection costs for
these tests are the same as the collection costs for random
tests. However, the FAA assumed that the cost associated
with collection of a small percentage of postaccident speci-
mens would be $100 per test. The FAA used this higher
figure to address the probability that postaccident speci-
mens may be collected at a remote accident site or a loca-
tion other than a site that the employer routinely collects
specimens. Conversely, specimens collected for testing

13la

based on reasonable cause or testing after return to duty
could be collected in a central location or at the same
location where other specimens are collected pursuant to
the requirements of the final rule.

Benefits. The FAA believes that three major benefits
will result from the promulgation of the final rule. First,
benefits will accrue from the prevention of potential in-
juries or fatalities and property losses due to accidents
attributed to neglect or error on the part of employees
performing sensitive safety- or security-related functions
whose motor skills or judgment may be impaired by
drugs. Second, benefits will accrue based on the poten-
tial reduction in employee absences from work, lost pro-
ductivity, reduced medical and insurance costs due to
on-the-job accidents, and improved general safety in the
workplace. Third, broad benefits in the development of
air commerce will accrue from projected diminished drug
use by commercial aviation employees, thereby increas-
ing public confidence in the commercial aviation transpor-
tation industry.

A review of the commercial aviation safety record shows
that drug use may have been a cause or factor in only
two recent aviation accidents. One accident was in 1983
and involved an all-cargo operation. The second accident
was in 1988 and involved a passenger operation. Both
accidents have been described previously in this rulemak-
ing document. Drug use has not been established as a
definitive causal factor of either accident. In the absence
of readily-available statistical data depicting the extent of
drug use by employees in commercial aviation and in light
of the pernicious effects of drug use, the FAA does not
consider the existing safety record to be an exclusive and
valid indicator of the threat to aviation safety posed by
aviation employee drug use. However, allegations of drug
use by the pilot and copilot of Continental Air Express
Flight 2286 that crashed on January 19, 1988, killing 9
people, reveal the significant and real potential for fatal

132a

aircraft accidents that may be related to the use of drugs
in commercial aviation. In light of data regarding drug
use by mechanics and repairmen submitted in response to
the ANPRM, the FAA also is concerned about the po-
tential for aviation accidents attributable to crug use by
commercial aviation maintenance personnel.

The FAA estimates that $84.3 million in discounted
benefits would result from promulgation of the final rule
if one accident attributed to drug-impaired performance
by an individual who performs a sensitive safety- or se-
curity-related function in commercial aviation, involving
a narrow-body, three-engine, commercial aircraft carrying
133 passengers and 5 crewmembers, is prevented during
the 10-year period from 1990 to 1999 (Exhibit E). Al-
though not claimed as a benefit in this Regulatory Im-
pact Analysis, the benefits associated with the prevention
of a single accident, during the 10-year period from 1990
to 1999, would be considerably more if the accident in-
volved a 4-engine, wide-body aircraft carrying 289 pas-
sengers and 19 crewmembers. In this event, discounted
benefits would total $219.9 million.

The FAA also attempted to estimate benefits of the
final rule, other than those benefits that may result from
the prevention of aircraft accidents, associated with di-
minished drug use by commercial aviation personnel or
any drug-deterrent effect that would result from promul-
gation of the final rule.

These estimated benefits consist of improved employee
productivity as a result of drug use deterrence. A report
released in 1987 by the National Institute on Drug Abuse
(NIDA), entitled “Strategic Planning for Workplace
Drug Abuse Programs,” reveals that drug and alcohol
abusers are involved in an additional 3.6 more accidents
than nonabusers; file 1.5 additional workers’ compensa-
tion claims than nonabusers; file 2.5 times more often for
sick leave of 8 or more consecutive days than nonabusers;

133a

and incur 3 times the amount of normal medical costs than
nonabusers.

In the absence of pertinent data, the FAA assumed that
the rate of drug use by the 538,000 covered aviation per-
sonnel] is approximately the same as the rate of drug use
in the general population (e.g., 10 percent). The FAA
also assumed that the productivity of employees who use
drugs is 95 percent of the productivity of employees who
do not use drugs.

In order to be conservative in estimating the costs of
the final rule, the FAA assumed that 7.5 percent of the
covered aviation personnel would product test results that
are confirmed positive for prohibited drug use. However,
this estimate is premised on testing that produces opti-
mum detection rates and the fact that drug users may
continue to use drugs despite implementation of compre-
hensive drug testing program that includes unannounced
testing based on random selection. Realistically, the FAA
expects that testing pursuant to the final rule will not
achieve optimum detection rates and that some drug users
will cease to use drugs rather than face the consequences
of being detected by testing under the final rule.

The FAA hypothesized that 1.0 percent of the affected
aviation population will stop using drugs voluntarily in
the face of a comprehensive drug testing program. These
individuals are expected to continue to perform sensitive
safety- or security-related functions without the presence
of drugs of drug metabolites in their systems. As noted
above, the FAA assumed that drug users are 95 percent
effective at their jobs compared to employees who do not
use drugs. Thus, the aviation industry would realize a
5 percent on-the-job productivity increase for each indi-
vidual who ceases to use drugs. Therefore, the FAA esti-
mated that employee productivity gains of $97.3 million,
or $54.3 million discounted over the 10-year period from
1990 to 1999, will accrue to the aviation industry based on

134a

the reduction of illegal drug use and increased employee
productivity (see Exhibit G).

Benefit/Cost Comparison. The total cost of compliance
with the requirements of the final rule is estimated to be
$240.3 million in 1987 dollars and $135.2 million, at a
present worth discount rate of 10 percent, over the pro-
jected 10-year period from 1990 to 1999. The FAA has
been unable to quantitatively estimate the accident pre-
vention effectiveness of the final rule. Nevertheless, the
FAA believes that drug use, unless stemmed, will continue
to pose athreat to aviation safety. The FAA estimates
that preventing one accident involving an average size,
commercial, passenger aircraft during the 10-year period
from 1990 to 1999 would result in discounted benefits of
$84.3 million. Likewise, discounted benefits ensuing from
increased employee productivity are estimated to be $54.3
million. Thus, total discounted benefits expected to result
from promulgation of the final rule amount to $138.6
million. The benefit to cost ratio of the final rule is 1.03.

Regulatory Flexibility Determination

The Regulatory Flexibility Act of 1980 requires a Fed-
eral agency to review any final rule to assess its impact
on smal! businesses. In consideration of the cost informa-
tion discussed previously and included in the full Regu-
latory Impact Analysis, the FAA certifies that the final
rule may have a significant negative economic impact on
a substantial number of small entities. In an effort to
relieve the burden on small entities, the FAA modified the
requirements of the final rule and provided alternative
schedules and implementation periods directed solely at
small aviation entities to provide some measure of relief
from the costs associated with the rule. The FAA antici-
pates that these modifications will reduce burdens associ-
ated with the requirements of the final rule on small en-
tities without adversely affecting aviation safety.

135a

International Trade Impact Statement

The final rule will affect only domestic operators and,
therefore, will have no impact on trade opportunities for
U.S. firms doing business overseas or on foreign firms
doing business in the United States. It should be noted
that, unless compliance with this final rule would violate
the domestic laws of policies of a foreign country or a
foreign government contends that application of the rule
raises questions of compatibility with foreign laws or poli-
cies, individuals employed at foreign repair stations under
contract to U.S. certificate holders would not be able to
perform maintenance or preventive maintenance work on
U.S.-rezistered aircraft unless they participate in an anti-
drug program. Thus, foreign repair stations may be af-
fected economically. Likewise, this program also will re-
sult in an expense to U.S. certificate holders operating
overseas because these entities will be required to establish
anti-drug programs, which will not be required of their
foreign competitors. The FAA is unable to estimate the
possible competitive effect of these costs.

Paperwork Reduction Act Approval

In order to ensure compliance and effectiveness of the
final rule, the FAA included necessary reporting and
recordkeeping requirements in the provisions of the final
rule. The final rule requires employers to maintain records
related to employee drug testing and any rehabilitation
and to submit periodic, written reports to the FAA that
summarize an employer’s anti-drug program. In accord-
ance with the Paperwork Reduction Act of 1980, the
recordkeeping and reporting requirements of the final rule
have been submitted to the Office of Management and
Budget (OMB) for approval.

Federalism Implications

The final rule adopted herein will not have substantial
direct effects on the States, on the relationship between
4

7

136a

the national government and the States, or on the dis-
tribution of power and responsibilities among the various
levels of government. This rule preempts any State or
local law that would prohibit or limit drug testing re-
quired under the rule. This preemption, under the FAA’s
statutory authority, is essential to ensure that the safety
benefits are obtained throughout the nation’s air trans-
portation system. The rule also could have an indirect,
economic impact on State and local governments, if per-
sons who lose jobs as a result of a positive drug test re-
quire welfare benefits or other public social services. The
FAA does not expect this impact to be significant, however.
Therefore, in accordance with Executive Order 12612, the
FAA determines that this final rule does not have sufficient
federalism implications to warrant preparation of a Fed-
eralism Assessment.

Conclusion

The final rule requires domestic and supplemental air
carriers, commercial operators of large aircraft, air taxi
and commuter operators, certain commercial operators,
certain contractors to these operators, located in the
United States or in a foreign country, and air traffic con-
trol facilities not operated by the FAA or the U.S. mili-
tary to have an anti-drug program for employees who
perform, either in the United States or in a foreign coun-
try, sensitive safety- or security-related functions. Test-
ing under this final rule will be conducted by an employer
prior to employment, periodically, randomly, after an
accident, based on reasonable cause, and after an em-
ployee returns to duty to perform a sensitive safety- or
security-related function for an employer. The final rule
also will require that an employer provide EAP education
and training services to employees and supervisors. The
rule is necessary to prohibit an employee from performing
a sensitive safety- or security-related function for an em-
ployer while that employee has a prohibited drug in his or
her system or if that employee has used drugs as evi-

137a

denced by a drug test showing the presence of drugs or
drug metabolites. The rule is intended to ensure a drug-
free aviation workforce and to eliminate drug use and
abuse in commercial aviation. The FAA believes that the
final rule will reduce the potential for drug-related avia-
tion accidents and will foster identification of commercial
aviation employees who use drugs.

Pursuant to the terms of the Regulatory Flexibility Act
of 1980, the FAA certifies that the final rule may have a
significant negative economic impact on a substantial
number of small entities. The final rule will not result in
an annual effect on the economy of $100 million or more,
but because the requirements of the final rule are im-
portant and costly undertakings, the FAA considers the
final rule to be a major rule pursuant to the criteria of
Executive Order 12291. In addition, the rule involves
issues of substantial interest to the public; this, the FAA
determines that the final rule is significant under the
Regulatory Policies and Procedures of the Department of
Transportation (44 FR 11034; February 2, 1979).

List of Subjects

14 CFR Part 61

Air safety, Air transportation, Aircraft, Aircraft pilots,
Airmen, Aviation safety, Drug Abuse, Drugs, Narcotics,
Pilots, Safety, Transportation.

14 CFR Part 63

Air safety, Air transportation, Aircraft, Airmen, Air-
planes, Aviation safety, Drug abuse, Drugs, Narcotics,
Safety, Transportation. .

14 CFR Part 65

Air safety, Air transportation, Aircraft, Airmen, Avia-
tion safety, Drug abuse, Drugs, Narcotics, Safety, Trans-
portation.

138a

14 CFR Part 121

Air carriers, Air transportation, Aircraft, Aircraft
pilots, Airmen, Airplanes, Aviation safety, Drug abuse,
Drugs, Narcotics, Pilots, Safety, Transportation.

14 CFR Part 135

Air carriers Air taxi, Air transportation, Aircraft,
Airmen, Airplanes, Aviation safety, Drug abuse, Drugs,
Narcotics, Pilots, Safety, Transportation.

The Amendment

Accordingly, the FAA amends Parts 61, 63, 65, 121,
and 185 of the Federal Aviation Regulations (14 CFR
Parts 61, 63, 65, 121, and 135) as follows:

PART 61—CERTIFICATION: PILOTS AND
FLIGHT INSTRUCTORS

1. The authority citation for Part 61 continues to
read as follows:

Authority: 49 U.S.C. 1354(a), 1856, 1421, 1422, and
1427; 49 U.S.C. 106(g) (Revised, Pub. L. 97-449, Janu-
ary 12, 1983).

2. By adding a new § 61.14 to read as follows:

§ 61.14 Refusal to submit to a drug test.
(a) This section applies to—

(1) An employee who performs a function listed in
Appendix I to Part 121 of this chapter for a Part 121
certificate holder or a Part 135 certificate holder; and

(2) An employee who performs a function listed in
Appendix I to Part 121 of this chapter for an operator
as defined in § 135.1(c) of this chapter. An employee
of a person conducting operations of foreign civil air-

139a

craft navigated within the United States pursuant to
Part 375 or emergency mail service operations pursuant
to Section 405(h) of the Federal Aviation Act of 1958
is excluded from the requirements of this section.

(b) Refusal by the holder of a certificate issued under
this part to take a test for a drug specified in Appendix I
to Part 121 of this chapter when requested by a cer-
tificate holder, by an operator as defined in § 135.1(c)
of this chapter, by a local law enforcement officer under
his or her own authority, or by an FAA inspector, under
the circumstances specified in that appendix, is grounds
for—

(1) Denial of an application for any certificate or rat-
ing issued under this part for a period of up to 1 year
after the date of that refusal; and

(2) Suspension or revocation of any certificate or rat-
ing issued under this part.
PART 683—CERTIFICATION: FLIGHT
CREWMEMBERS OTHER THAN PILOTS

3. The authority citation for Part 63, Subpart A, is
revised to read as follows:

Authority: 49 U.S.C. 1354(a), 13855, 1421, 1422, 1427,
1429, and 1430; 49 U.S.C. 106(g) (Revised, Pub. L.
97-449, January 12, 1983).

4. By adding a new § 63.12b to read as follows:

§ 63.12b Refusal to submit to a drug test.
(a) This section applies to—

(1) An employee who performs a function listed in
Appendix I to Part 121 of this chapter for a Part 121
certificate holder or a Part 135 certificate holder; and

(2) An employee who performs a function listed in
Appendix I to Part 121 of this chapter for an operator

140a

as defined in § 185.1(c) of this chapter. An employee of
a person conducting operations of foreign civil aircraft
navigated within the United States pursuant to Part 375
or emergency mail service operations pursuant to section
405(h) of the Federal Aviation Act of 1958 is excluded
from the requirements of this section.

(2) Refusal by the holder of a certificate issued under
this part to take a test for a drug specified in Appendix I
to Part 121 of this chapter when requested by a cer-
tificate holder, by an operator as defined in § 135.1(c) of
this chapter, by a local law enforcement officer under
his or her own authority, or by an FAA inspector, under
the circumstances specified in that appendix, is grounds
for—

(1) Denial of an application for any certificate or rat-
ing issued under this part for a period of up to 1 year
after the date of that refusal; and

(2) Suspension or revocation of any certificate or rat-
ing issued under this part.
PART 65—CERTIFICATION: AIRMEN OTHER
THAN FLIGHT CREWMEMBERS

5. The authority citation for Part 65 continues to
read as follows:

Authority: 49 U.S.C. 1354, 1855, 1421, 1422, and
1427; 49 U.S.C. 106(g) (Revised, Pub. L. 97-449; Janu-
ary 12, 1983).

6. By adding a new § 65.23 to read as follows:

§ 65.23 Refusal to submit to a drug test.
(a) This section applies to—

(1) An employee who performs a function listed in
Appendix I to Part 121 of this chapter for a Part 121
certificate holder or a Part 1395 certificate holder;

14la

(2) An employee who performs a function listed in
Appendix I to Part 121 of this chapter for an operator
as defined in § 135.1(c) of this chapter. An employee of
a person conducting operations of foreign civil aircraft
navigated within the. United States pursuant to Part 375
or emergency mail service operations pursuant to section
405(h) of the Federal Aviation Act of 1958 is excluded
from the requirements of this section; and

(3) An employee of an air traffic control facility not
operated by, or under contract with, the FAA or the U.S.
military.

(b) Refusal by the holder of a certificate issued under
this part to take a test for a drug specified in Appendix I
to Part 121 of this chapter when requested by a certifi-
cate holder, by an operator as defined in § 135.1(c) of this
chapter, by an employer as defined in § 65.46 of this
part, by a local law enforcement officer under his or her
own authority, or by an FAA inspector, under the cir-
cumstances specified in that appendix, is grounds for—

(1) Denial of an application for any certificate or rat-
ing issued under this part for a period of up to 1 year
after the date that that refusal; and

(2) Suspension or revocation of any certificate or rat-
ing issued under this part.

7. By adding a new § 65.46 to read as follows:

§ 65.46 Use of prohibited drugs.

(a) The following definitions apply for the purposes
of this section:

(1) An “employee” is a person who performs an air
traffic control function for an employer. For the purpose
of this section, a person who performs such a function
pursuant to a contract with an employer is considered to
be performing that function for the employer.

EE Oe re Cre

142a

(2) An “employer” means an air traffic control facility
not operated by, or under contract with, the FAA or the
U.S. military that employs a person to perform an air
traffic control function.

(b) Each employer shall provide each employee per-
forming a function listed in Appendix I to Part 121 of
this chapter and his or her supervisor with the training
specified in that appendix. No employer may use any
contractor to perform an air traffic control function un-
less that contractor provides each of its employees per-
forming that function for the employer and his or her
supervisor with the training specified in that appendix.

(c) No employer may knowingly use any person to
perform, nor may any person perform for an employer,

- either directly or by contract, any air traffic control func-

tion while that person has a prohibited drug, as defined
in Appendix I to Part 121 of this chapter, in his or her
system.

(d) Except as provided in paragraph (e) of this sec-
tion, no employer may knowingly use any person to per-
form, nor may any person perform for an employer,
either directly or by contract, any air traffic control func-
tion if that person failed a test or refused to submit to
a test required by Appendix I to Part 121 of this chapter
given by a certificate holder, by an employer, or by an
operator as defined in § 135.1(c) of this chapter.

(e) Paragraph (d) of this section does not apply to a
person who has received a recommendation to be hired
or to return to duty from a medical review officer in
accordance with Appendix I to Part 121 of this chapter
or who has received a special issuance medical certificate
after evaluation by the Federal Air Surgeon for drug
dependency in accordance with Part 67 of this chapter.

(f) Each employer shall test each of its employees who
performs any air traffic control function in accordance
with Appendix I to Part 121 of this chapter. No em-

143a

ployer may use any contractor to perform any air traffic
control function unless that contractor tests each em-
ployee performing such a function for the employer in
accordance with that appendix.

PART 121—CERTIFICATION AND OPERATIONS:

DOMESTIC, FLAG, AND SUPPLEMENTAL AIR

CARRIERS AND COMMERCIAL OPERATORS OF
LARGE AIRCRAFT

8. The authority citation for Part 121 continues to
read as follows:

Authority: 49 U.S.C. 1354(a), 1355, 1356, 1357, 1401,
1421-1430, 1472, 1485, and 1502; 49 U.S.C. 106(g) (Re-
vised, Pub. L. 97-499, January 12, 1983).

9. By adding a new § 121.429 to read as follows:

§ 121.429 Prohibited drugs.

(a) Each certificate holder shall provide each employee
performing a function listed in Appendix I to this part
and his or her supervisor with the training specified in
that appendix.

(b) No certificate holder may use any contractor to
perform a function listed in Appendix I to this part un-
less that contractor provides each of its employees per-
forming that function for the certificate holder and his
or her supervisor with the training specified in that
appendix.

10. By adding a new § 121.455 to read as follows:

§ 121.455 Use of prohibited drugs.

(a) This section applies to persons who perform a
function jisted in Appendix I to this part for the certifi-
cate holder. For the purpose of this section, a person who
performs such a function pursuant to a contract with the

70 SS See
le

144a

catttificate holder is considered to be pereernng that func-
tion for the certificate holder.

(b) No certificate holder may knowingly use any per-
son to perform, nor may any person perform for a cer-
tificate holder, either directly or by contract, any function
listed in Appendix I to this part while that person has a
prohibited drug, as defined in that appendix, in his or her
system.

(c) Except as provided in paragraph (d) of this sec-
tion, no certificate holder may knowingly use any person
to perform, nor may any person perform for a certificate
holder, either directly or by contract, any function listed
in Appendix I to this part if that person failed a test or
refused to submit to a test required by that appendix
given by a certificate holder or an operator as defined in
§ 135.1(c) of this chapter.

(d) Paragraph (c) of this section does not apply to a
person who has received a recommendation to be hired or
to return to duty from a medical review officer in ac-
cordance with Appendix I to Part 121 of this chapter or
who has received a special issuance medical certificate
after evaluation by the Federal Air Surgeon for drug
dependency in accordance with Part 67 of this chapter.

11. By adding a new § 121.457 to read as follows:

§ 121.457 Testing for prohibited drugs.

(a) Each certificate holder shall test each of its em-
ployees who performs a function listed in Appendix I to
this part in accordance with that appendix.

(b) No certificate holder may use any contractor to
perform a function listed in Appendix I to this part un-
less that contractor tests each employee performing such
a function for the certificate holder in acocrdance with
that appendix. .

145a

12. By adding a new Appendix I to Part 121 to read
as follows:

Appendix I—Drug Testing Program

This appendix contains the standards and components
that must be included in an anti-drug program required
by this chapter.

I. DOT Procedures. Each employer shall ensure that
drug testing programs conducted pursuant to this regula-
tion comply with the requirements of this appendix and
the “Procedures for Transportation Workplace Drug
Testing Programs” published by the Department of
Transportation (DOT) (49 CFR Part 40). An employer
may not use or contract with any drug testing laboratory
that is not certified by the Departmert of Health and
Human Services (DHHS) pursuant to the DHHS “Man-
datory Guidelines for Federal Workplace Drug Testing
Programs” (53 FR 11970; April 11, 1988).

II. Definitions. For the purpose of this appendix, the
following definitions apply:

“Accident” means an occurrence associated with the
operation of an aircraft which takes place between the
time any person boards the aircraft with the intention
of flight and all such persons have disembarked, and in
which any person suffers death or serious injury, or in
which the aircraft receives substantial damage (49 CFR
830.2).

“Annualized rate” for the purposes of unannounced
testing of employees based on random selection means the
percentage of specimen collection and testing of employees
performing a function listed in section III of this ap-
oendix during a calendar year. The employer shall deter-
mine the annualized percentage rate by referring to the
cotal number of employees performing a sensitive safety-
or security-related function for the employer at the be-
ginning of a calendar year or by an alternative method

146a

specified in the employer’s drug testing plan approved by
the FAA.

“Employee” is a person who performs, either directly
or by contract, a function listed in section III of this
appendix for a Part 121 certificate holder, a Part 135
certificate holder, an operator as defined in § 135.1(c) of
this chapter (except operations of foreign civil aircraft
navigated within the United States pursuant to Part 375
or emergency mail service operations pursuant to section
405(h) of the Federal Aviation Act of 1958), or an air
traffic control facility not operated by, or under contract
with, the FAA or the U.S. military. Provided however
that an employee who works for an employer who holds
a Part 135 certificate and who also holds a Part 121
certificate is considered to be an employee of the Part 121
certificate holder for the purposes of this appendix.

“Employer” is a Part 121 certificate holder, a Part 135
certificate holder, an operator as defined in § 135.1(c) of
this chapter (except operations of foreign civil aircraft
navigated within the United States pursuant to Part 375
or emergency mail service operations pursuant to Section
405(h) of the Federal Aviation Act of 1958), or an..air
traffic control facility not operated by, or under contract
with, the FAA or the U.S. military. Provided, however,
that an employer may use a person to perform a function
listed in section III of this appendix, who is not included
under that employer’s drug program, if that person is
subject to the requirements of another employer’s FAA-
approved anti-drug program.

“Failing a drug test” means that the test result shows
positive evidence of the presence of a prohibited drug or
drug metabolite iri an employee’s system.

“Passing a drug test” means that the test result does
not show positive evidence of the presence of a prohibited
drug or drug metabolite in an employee’s system.

147a

“Positive evidence’ means the presence of a drug or
drug metabolite in a urine sample at or above the test
levels listed in the DOT “Producers for Transportation
Workplace Drug Testing Programs” (49 CFR Part 40).

“Prohibited drug’ means marijuana, cocaine, opiates,
phencyclidine (PCP), amphetamines, or a substance spec-
ified in Schedule I or Schedule II of the Controlled Sub-
stances Act, 21 U.S.C. 811, 812 (1981 & 1987 Cum.
P.P.), unless the drug is being used as authorized by a
legal prescription or other exemption under Federal,
state, or local law.

“Refusal to submit” means refusal by an individual
to provide a urine sample after he or she has received
notice of the requirement to be tested in accordance with
this appendix.

Ill. Employees Who Must Be Tested. Each person
who performs a function listed in this section must be
tested pursuant to an FAA-approved anti-drug pro-
gram conducted in accordance with this appendix:

a. Flight‘crewmember duties.

b. Flight attendant duties.

ce. Flight instruction or ground instruction duties.
d. Flight testing duties.

e. Aircraft dispatcher or ground dispatcher duties.

f. Aircraft maintenance or preventive maintenance
duties.

g. Aviation security or screening duties.

h. Air traffic control duties.

IV. Substances For Which Testing Must Be Con-
ducted. Each employer shall test each employee who per-
forms a function listed in section III of this appendix
for evidence of marijuana, cocaine, opiates, phencyclidine
(PCP), and amphetamines durirfg each test required by

148a

section V of this appendix. As part of reasonable cause
drug testing program established pursuant to this part,
employers may test for drugs in addition to those speci-
tied in this part only with approval granted by the FAA
under 49 CFR Part 40 and for substances for which the
Department of Health and Human Services has estab-
lished an approved testing protocol and positive thresh-
hold.

V. Types of Drug Testing Required. Each employer
shall conduct the following types of testing in accord-
ance with the procedures set forth in this appendix and
the DOT “Procedures for Transportation Workplace
Drug Testing Programs” (49 CFR Part 40):

A. Preemployment testing. No employer may hire any
person to perform a function listed in section III of this
appendix unless the applicant passes a drug test for that
employer. The employer shall advise an applicant at the
time of application that preemployment testing will be
conducted to determine the presence of marijuana, co-
caine, opiates, phencyclidine (PCP), and amphetamines
or a metabolite of those drugs in the applicant’s system.

B. Periodic testing. Each employee who performs a
function listed in section III of this appendix for an em-
ployer and who is required to undergo a medical ex-
amination under Part 67 of this chapter, shall submit
to a periodic drug test. The employee shall be tested for
the presence of marijuana, cocaine, opiates, phencylidine
(PCP), and amphetamines or a metabolite of those drugs
as part of the first medical evaluation of the employee
during the first calendar year of implementation of the
employer’s anti-drug program. An employer may dis-
continue periodic testing of its employees after the first
calendar year of implementation of the employer’s anti-
drug program when the employer has implemented an
unannounced testing program based on random selection
of employees.

149a

C. Random testing. Each employer shall randomly se-
lect employees who perform a function listed in section
III of this appendix for the employer for unannounced
drug testing. The employer shall randomly select em-
ployees for unannounced testing for the presence of
marijuana, cocaine, opiates, phencyclidine (PCP), and
amphetamines or a metabolite of those drugs in an em-
ployee’s system using a random number table or a com-
puter-based, number generator that is matched with an
employee’s social security number, payroll identification
number, or any other alternative method approved by the
FAA.

(1) During the first 12 months following implementa-
tion of unannounced testing based on random selection
pursuant to this appendix, an employer shall meet the
following conditions:

(a) The unannounced testing based on random selec-
tion of employees shall be spread reasonably throughout
the 12-month period.

(b) The last collection of specimens for random test-
ing during the year shall be conducted at an annualized
rate equal to not less than 50 percent of employees per-
forming a function listed in section III of this appendix.

(c) The total number of unannounced tests based on
random selection during the 12-months shall be equal to
not less than 25 percent of the employees performing a
function listed in section III of this appendix.

(2) Following the first 12 months, an employer shall
achieve and maintain an annualized rate equal to not
less than 50 percent of employees performing a function
listed in section III of this appendix.

D. Postaccident testing. Each employer shall test each
employee who performs a function listed in section III
of this appendix for the presence of marijuana, cocaine,
opiates, phencyclidine (PCP), and amphetamines or a

150a

metabolite of those drugs in the employee’s system if
that employee’s performance either contributed to an ac-
cident or cannot be completely discounted as a contribut-
ing factor to the accident. The employee shall be tested
as soon as possible but not later than 32 hours after the
accident. The decision not to administer a test under this
section must be based on a determination, using the best
information available at the time of the accident, that
the employee’s performance could not have contributed
to the accident. The employee shall submit to postacci-
dent testing under this section.

E. Testing based on reasonable cause. Each employer
shall test each employee who performs a function listed
in section III of this appendix and who is reasonably
suspected of using a prohibited drug. Each employer
shall test an employee’s specimen for the presence of
marijuana, cocaine, opiates, phencyclidine (PCP), and
amphetamines or a metabolite of those drugs. An em-
ployer may test an employee’s specimen for the presence
of other prohibited drugs or drug metabolites only in ac-
cordance with this appendix and the DOT “Procedures
for Transportation Workplace Drug Testing Programs”
(49 CFR Part 40). At least two of the employee’s su-
pervisors, one of whom is trained in detection of the pos-
sible symptoms of drug use, shall substantiate and con-
cur in the decision to test an employee who is reasonably
suspected of drug use. In the case of an employer hold-
ing a Part 135 certificate who employs 50 or fewer em-
ployees who perform a function listed in section III of
this appendix or an operator as defined in § 135.1(c) of
this chaptey, one supervisor, who is trained in detection
of possible symptoms of drug use, shall substantiate the
decision to test an employee who is reasonably suspected
of drug use. The decision to test must be based on a rea-
sonable and articulable belief that the employee is using
a prohibited drug on the basis of specific, contemporane-
ous physical, behavioral, or performance indicators of
probable drug use.

15la

F. Testing ajter return to duty. Each employer shall
implement a reasonable program of unannounced testing
of each individual who has been hired and each employee
who has returned to duty to perform a function listed
in section III of this appendix after failing a drug test
conducted in accordance with this appendix or after re-
fusing to submit to a drug test required by this ap-
pendix. The individual or employee shall be subject to
unannounced testing for not more than 60 months after
the individual has been hired or the employee has re-
turned to duty to perform a function listed in section
III of this appendix.

VI. Administrative Matters—A. Collection, testing,
and rehabilitation records. Each employer shall maintain
all records related to the collection process, including all
logbooks and and certification statements, for two years.
Each employer shall maintain records of employee con-
firmed positive drug test results and employee rehabilita-
tion for five years. The employer shall maintain records
of negative test results for 12 months. The employer
shall permit the Administrator or the Administrator’s
representative to examine these records.

B. Laboratory inspections. The employer shall con-
tract only with a laboratory that permits pre-award in-
spections by the employer before the laboratory is awarded
a testing contract and unannounced inspections, including
examination of any and all records at any time by the em-
ployer, the Administrator, or the Administrator’s repre-
sentative.

C. Employee request to retest a specimen. Not later
than 60 days after receipt of a confirmed positive test
result, an employee may submit a written request to the
MRO for retesting of the specimen producing the positive
test result. Each employee may make one written request
that a sample of the specimen be provided to the original
or another DHHS-certified laboratory for testing. The
laboratories shall follow chain-of-custody procedures. The

152a

employee shall pay the costs of the additional test and all
handling and shipping costs associated with the transfer
of the specimen to the laboratory.

D. Release of Drug Testing Information. An employer
may release information regarding an employee’s drug
testing results or rehabilitation to a third party only with
the specific, written consent of the employee authorizing
release of the information to an identified person. Infor-
mation regarding an employee’s drug testing results or re-
habilitation may be released to the National Transporta-
tion Safety Board as part of an accident investigation, to
the FAA upon request, or as required by section VII.C.5
of this appendix.

VII. Review of Drug Testing Results. The employer
shall designate or appoint a medical review officer (MRO).
If the employer does not have a qualified individual on
staff to serve as MRO, the employer may contract for pro-
vision of MRO services as part of its drug testing pro-
gram.

A. MRO qualifications. The MRO must be a licensed
physician with knowledge of drug abuse disorders.

B. MRO duties. The MRO shall perform the following
functions for the employer:

1. Review the results of the employer’s drug testing
program before the results are reported the employer and
summarized for the FAA.

2. Within a reasonable time, notify an employee of a
confirmed positive test result.

3. Review and interprét each confirmed positive test
result in order to determine if there is an alternative medi-
cal explanation for the confirmed positive test result. The
MRO shall perform the following functions as part of the
review of a confirmed positive test result:

a. Provide an opportunity for the employee to discuss
a positive test result with the MRO.

ae Ppa c we,

158a

b. Review the employee’s medical history and any
relevant biomedical factors.

c. Review all medical records made available by the
employee to determine if a confirmed positive test resulted
from legally prescribed medication.

d. Verify that the laboratory report and assessment
are correct. The MRO shall be authorized to request that
the original specimen be reanalyzed to determine the ac-
curacy of the reported test result.

4. Process employee requests to retest a specimen in
accordance with section VI.C of this appendix.

5. Determine whether and when, consistent with an
employer’s anti-drug program, a return-to-duty recom-
mendation for a current employee or a decision to hire an
individual to perform a function listed in section III of
this appendix after failing a test conducted in accordance
with this appendix or after refusing to submit to a test
required by this appendix, including review of any re-
habilitation program in which the individual or employee
participated, may be made.

6. Ensure that an individual employee has been tested
in accordance with the procedures of this appendix and
the DOT ‘‘Procedures for Transportation Workplace Drug
Testing Programs” (49 CFR Part 40) before the indi-
vidual is hired or the employee returns to duty.

7. Determine a schedule of unannounced testing for an
individual who has been hired or an employee who has
returned to duty to perform a function listed in section
III of this appendix after the individual or employee has
failed a drug test conducted in accordance with this ap-
pendix or has refused to submit to a drug test required
by this appendix.

C. MRO determinations. 1. If the MRO determines,
after appropriate review, that there is a legitimate medi-

154a

cal explanation for the confirmed positive test result that
is consistent with legal drug use, the MRO shall conclude
that the test result is negative and shall report the test
as a negative test result.

2. If the MRO determines, after appropriate review,
that there is no legitimate medical explanation for the
confirmed positive test result that is consistent with legal
drug use, the MRO shall refer the employee to an employ-
er’s rehabilitation program that is available or to a per-
sonnel or administrative officer for further proceedings in
accordance with the employer’s anti-drug program.

3. Based on a review of laboratory inspection reports,
quality assurance and quality control data, and other drug
test results, the MRO may conclude that a particular drug
test is scientifically insufficient for further action. Under
these circumstances, the MRO shall conclude that the test
is negative for the presence of drugs or drug metabolites
in an employer’s system.

4. In order to make a recommendation to hire an indi-
vidual to perform a function listed in section III of this
appendix or to return an employee to duty to perform a
function listed in section III of this appendix after the
individual or employee has failed a drug test conducted
in accordance with this appendix or refused to submit to
a drug test required by this appendix, the MRO shali—

a. Ensure that the individual or employee is drug free
based on a drug test that shows no positive evidence of the
presence of a drug or a drug metabolite in the person’s
system ;

b. Ensure that the individual or employee has been
evaluated by a rehabilitation program counselor for drug
use or abuse; and

ce. Ensure that the individual or employee demon-
strates compliance with any conditions or requirements of
a rehabilitation program in which the person participated.

155a

5. Notwithstanding any other section in this appendix,
the MRO shall make the following determinations in the
case of an employee or applicant who holds, or is required
to hold, a medical certificate issued pursuant to Part 67
of this chapter in order to perform a function listed in sec-
tion III of this appendix for an employer:

a. The MRO shall make a determination of probable
drug dependence or nondependence as specified in Part 67
of this chapter. If the MRO makes a determination of non-
dependence, the MRO has authority to recommend that the
employer return to duty in a position that requires the
employee to hold a certificate issued under Part 67 of this
chapter. The MRO shall forward the determination of non-
dependence, the return-to-work decision, and any support-
ing documentation to the Federal Air Surgecn for review.

b. If the MRO makes a determination of probable drug
dependence at any time, the MRO shall report the name
of the individual and identifying information, the de-
termination of probable drug dependence, and any support-
ing documentation to the Federal Air Surgeon. The MRO
does not have the authority to recommend that the em-
ployees return to duty in a position that requires the em-
ployee to hold a certificate issued under Part 67 of this
chapter. The Federal Air Surgeon shall determine if the
individual may retain or may be issued a medical certifi-
cate consistent with the requirements of Part 67 of this
chapter.

ce. The MRO shall report to the Federal Air Surgeon
the name of any employee who is required to hold a medi-
cal certificate issued pursuant to Part 67 of this chapter
and who fails a drug test. The MRO shall report to the
Federal Air Surgeon the name of any person who applies
for a position that requires the person to hold a medical
certificate issued pursuant to Part 67 of this chapter and
who fails a preemployment drug test.

d. The MRO shall forward the information specified in
paragraphs (a), (b), and (c) of this section to the Fed-

156a

eral Air Surgeon, Federal Aviation Administration, Drug
Abatement Branch (AAM-220), 800 Independence Avenue,
SW., Washington, DC. 20591.

VIII. Employee Assistance Program (EAP). The em-
ployer shall provide an EAP for employees. The em-
ployer may establish the EAP as part of its internal per-
sonnel services or the employer may contract with an
entity that will provide EAP services to an employee.
Each EAP must include education and training on drug
use for employees and training for supervisors making
determinations for testing of employees based on reason-
able cause.

A. EAP education program. Each EAP education pro-
gram must include at least the following elements: display
and distribution of informational material; display and
distribution of a community service hot-line telephone
number for employee assistance; and display and distri-
bution of the employer’s policy regarding drug use in the
workplace.

B. EAP training program. Each employer shall im-
plement a reasonable program of initial training for em-
ployees. The employee training program must include at
least the following elements: The effects and consequences
of drug use on personal health, safety, and work environ-
ment; the manifestations and behavioral cues that may
indiciate drug use and abuse; and documentation of train-
ing given to employees and employer’s supervisory per-
sonnel. The employer’s supervisory personnel who will de-
termine when an employee is subject to testing based on
reasonable cause shall receive specific training on the
specific, contemporaneous physical, behavioral, and per-
formance indicators of probable drug use in addition to
the training specified above. The employer shall ensure
that supervisors who will make reasonable cause determi-
nations receive at least 60 minutes of initial training.
The employer shall implement a reasonable recurrent
training program for supervisory personnel making rea-

157a

sonable cause determinations during subsequent years.
The employer shall identify the employee and supervisor
EAP training in the employer’s drug testing plan sub-
mitted to the FAA for approval.

IX. Employer’s Drug Testing Plan—A. Schedule for
submission of plans and implementation. (1) Each em-
ployer shall submit a drug testing plan to the Federal
Aviation Administration, Office of Aviation Medicine,
Drug Abatement Branch (AAM-220), 800 Independence
Avenue, SW., Washington, DC 20591.

(2) Each employer who holds a Part 121 certificate and
each employer who holds a Part 135 certificate and em-
ploys more than 50 employees who perform a function
listed in section III of this appendix shall submit an
anti-drug program to the FAA (specifying the procedures
for all testing required by this appendix) not later than
120 days after December 21, 1988. Each employer shall
implement preemployment testing of applicants for a posi-
tion to perform a function listed in section III of this ap-
pendix not later than 10 days after approval of the plan
by the FAA. Each employer shall implement the re-
mainder of the employer’s anti-drug program no later
than 180 days after approval of the plan by the FAA.

(3) Each employer who holds a Part 135 certificate
and employs from 11 to 50 employees who perform a func-
tion listed in section III of this appendix shall submit an
interim anti-drug program to the FAA (specifying the
procedures for preemployment testing, periodic testing,
postaccident testing, testing based on reasonable cause, and
testing after return to duty) not later than 180 days after
December 21, 1988. Each employer shall implement the
interim anti-drug program not later than 180 days after
approval of the plan by the FAA. Each employer shall
submit an amendment to its approved anti-drug program
to the FAA (specifying the procedures for unannounced
testing based on random selection) not later than 120

158a

days after approval of the interim anti-drug program by
the FAA. Each employer shall implement the random
testing provision of its amended anti-drug program not
later than 180 days after approval of the amendment.

(4) Each employer who holds a Part 135 certificate and
employs 10 or fewer employees who perform a function
listed in section III of this appendix, each operator as de-
fined in § 135.1(c) of this chapter, and each air traffic
control facility not operated by, or under contract with
the FAA or the U.S. military, shall submit an anti-drug
program to the FAA (specifying the procedures for all
testing required by this appendix) not later than 360
days after December 21, 1988. Each employer shall im-
plement the employer’s anti-drug program not later than
180 days after approval of the plan by the FAA.

(5) Each employer or operator, who becomes subject to
the rule as a result of the FAA’s issuance of a Part 121
or Part 135 certificate or as a result of beginning opera-
tions listed in § 135.1(b) for compensation or hire (except
operations of foreign civil aircraft navigated within the
United States pursuant to Part 375 or emergency mail
service operations pursuant to section 405(h) of the Fed-
eral Aviation Act of 1958) shall submit an anti-drug
plan to the FAA for approval, within the timeframes of
paragraph (2), (3) or (4) of this section, according to
the type and size of the category of operations. For pur-
poses of applicability of the timeframes, the date that an
employer becomes subject to the requirements of this ap-
pendix is substituted for [the effective date of the rule}.

B. An employer’s anti-drug plan must specify the
methods by which the employer will comply with the test-
ing requirements of this appendix. The plan must pro-
vide the name and avdress of the laboratory which has
been selected by the employer for analysis of the specimens
collected during the employer’s anti-drug testing program.

C. An employer’s anti-drug plan must specify the pro-
cedures and personnel the employer will use to ensure

159a

that a determination is made as to the veracity of test
results and possible legitimate explanations for an em-
ployer failing a test.

D. The employer shall consider its anti-drug program
to be approved by the Administrator, unless notified to
the contrary by the FAA, within 60 days after submission
of the plan to the FAA.

X. Reporting Resuits of Drug Testing Program, A.
Each employer shall submit a semiannual report to the
FAA summarizing the results of its drug testing pro-
gram and covering the period from January 1-June 30.
Each employer shall submit an annual report to the FAA
summarizing the results of its drug testing program and
covering the period from January 1-December 31. Each
employer shall submit these reports no later than 45 days
after the last day of the report period.

B. Each report shall contain:

1. The total number of tests performed and the total
number of tests performed for each category of test.

2. The total number of positive test results by cate-
gory of test; the total number of positive test results by
each function listed in section III of this appendix; and
the total number of positive test results by the type of
drug shown in a positive test result.

8. The disposition of an individual who failed a drug
test conducted in accordance with this appendix or who
refused to submit to a drug test required by this appendix
by each category of test.

XI. Preemption. A. The issuance of these regulations
by the FAA preempts any State or local law, rule, regu-
lation, order, or sta

[Text truncated at 120,000 characters. The full text is on the page linked above.]

---

Source: Frix Law Library, https://www.frixlaw.com/law-library/documents/brief%3Amicro_IA40385020_3070%3A2. Public record. Not legal advice.
